Journey beyond immunology. Regulation of receptor internalization by major histocompatibility complex class I (MHC-I) and effect of peptides derived from MHC-I

APMIS, Supplement

Volumn 106, Issue 85, 1998, Pages 5-40

  Stagsted, Jan ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN TYROSINE KINASE;

CELL MEMBRANE TRANSPORT; ENZYME ACTIVATION; ENZYME ACTIVITY; GLUCOSE TRANSPORT; HUMAN; INTERNALIZATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84865930676     PISSN: 0903465X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0463.1998.tb05657.x     Document Type: Article

References (553)

1. T. Hansen, J. Stagsted, L. Pedersen, R. A. Roth, A. Goldstein, and L. Olsson. Inhibition of insulin receptor phosphorylation by peptides derived from major histocompatibility complex class I antigens. Proc. Natl. Acad. Sci. USA 86,3123-6(1989)
2. J. Stagsted, G. M. Reaven,T. Hansen, A. Goldstein, and L Olsson. Regulation of insulin receptor functions by a peptide derived from a major histocompatibility complex class I antigen. Cell 62,297-307 (1990)
3. J. Stagsted, S. Ziebe, & Satoh, G. D. Holman, S. W. Cushman, and L. Olsson. Insulinomimetic effect on glucose transport by epidermal growth factor when combined with a major histocompatibility complex class I-derived peptide. J. Biol. Chem. 268,1770-4 (1993)
4. J. Stagsted, L. Olsson, G. D. Holman, S.W. Cushman, and S. Satoh. Inhibition of internalization of glucose transporters and IGF-II receptors. Mechanism of action of MHC class I-derived peptides which augment the insulin response in rat adipose cells. J. Biol. Chem. 268,22809-13 (1993)
5. J. Stagsted.T. Hansen, R. A. Roth, A. Goldstein, and L. Olsson. Correlation between insulin receptor occupancy and tyrosine kinase activity at low insulin concentrations and effect of major histocompatibility complex class I-derived peptide. J. Pharmacol. Exp.Ther. 267,997-1001 (1993)
6. L. Olsson, A. Goldstein, and J. Stagsted. Regulation of receptor internalization by the major histocompatibility complex class I molecule. Proc Natl. Acad. Sci. USA 91,9086-90 (1994)
7. J. Stagsted, W. A. Baase, A. Goldstein, and L. Olsson. A preformed, ordered structure of a 25-residue peptide derived from a major histocompatibility complex class I antigen is required to affect insulin receptor function. J. Biol Chem. 266,12844-7 (1991)
8. J. Stagsted, C. Mapelli, C. A. Meyers, B. W. Matthews, C. B. Anfinsen, A. Goldstein, and L. Olsson. Amino acid residues essential for biological activity of a peptide derived from a major histocompatibility complex class I antigen. Proc. Natl Acad. Sci. USA 90,7686-90 (1993)
9. L. Weaver, J. Stagsted, O. Behnke, B. W. Matthews, and L. Olsson. β-Sheet models for the ordered filamentous structure formed by a peptide that enhances the action of insulin. J. Struct. Biol. 117,165-72 (1996)
10. M. Simonsen and L. Olsson. Possible roles of compound membrane receptors in the immune system. Ann. Immunol. Paris. 134D,85-92 (1983)
11. M. Simonsen, K. Skjodt, M. Crone, A. Sanderson,Y FujitaYamaguchi, C Due, E. Ronne, K. Linnet, and L. Olssoa Compound receptors in the cell membrane: ruminations from the borderland of immunology and physiology. Prog. Allergy. 36,151-76(1985)
12. C. Due, M. Simonsen, and L. Olssoa The major histocompatibility complex class I heavy chain as a structural subunit of the human cell membrane insulin receptor: Implications for the range of biological functions of histocompatibility antigens. Proc. Natl. Acad. Sci. USA 83,6007-11 (1986)
13. S.Verland, M. Simonsen, S. Gammeltoft, H. Allen, R. A. Flavell, and L. Olsson. Specific molecular interaction between the insulin receptor and a D product of MHC class 1.1 Immunol. 143,945-51 (1989)
14. Y. Chvatchko, E. van Obberghen, N. Kiger, and M. Fehlmann. Immunoprecipitation of insulin receptors by antibodies against class I antigens of the murine H-2 major histocompatibility complex. FEBS Lett. 163,207-11 (1983)
15. M. Fehlman, J.-F. Peyron, M. Samson, E. van Obberghen, D. Brandenburg, and N. Broselte. Molecular association between major histocompatibility complex class I antigens and insulin receptors in mouse liver membranes. Proc. Natl. Acad. Sci. USA 82,8634-7 (1985)
16. M. Samson, J. L. Cousin, and M. Fehlmann. Cross-linking of insulin receptorsto MHC antigens in human B lymphocytes: evidence for selective molecular interactions. J. Immunol. 137,2293-8 (1986)
17. M. L. Philips, M. L. Moule,T. L. Delovitch, and C C Yip. Class I histocompatibility antigens and insulin receptors: Evidence for interactions. Proc. Natl. Acad. Sci. USA 83,3474-8 (1986)
18. C C Yip, M. L. Moule, C Hirstwood, B. Cinader, and M. L. Phillips. Class I histocompatibility antigens and insulin receptors: Evidence forage-dependent interactions. In The Immunology of Diabetes Mellitus, Jaworski,M. A. et aL (editors) 215-22 (1986)
19. D. Meruelo and M. Edidin. Association of mouse liver adenosine 3 :5 -cyclic monophosphate (cyclic AMP) levels with histocompatibility-2 genotype. Proc. Natl. Acad. Sci. USA 72,2644-8 (1975)
20. W Lafuse and M. Edidin. Influence of the mouse major histocompatibility complex, H-2, on liver adenylate cyclase activity and on glucagon binding to liver cell membranes. Biochem. 19,49-54 (1980)
21. A. B. Schreiber, J. Schlessinger, and M. Edidin. Interaction between major histocompatibility complex antigens and epidermal growth factor receptors on human cells. J. Cell Biol. 98,725-31 (1984)
22. D. Kittur.Y. Shimizu, R. DeMars, and M. Edidin. Insulin binding to human B lymphoblasts is a function of HLA haplotype. Proc. Natl. Acad. Sci. USA 84,1351-5(1987)
23. M. Edidin and I Reiland. Dynamic measurements of associations between class I MHC antigens and insulin receptors. Mol Immunol. 27,1313-7 (1990)
24. J. Reiland and M. Edidin. Chemical cross-linking detects association of insulin receptors with four different class I human leukocyte antigen molecules on cell surfaces. Diabetes 42,619-25 (1993)
25. T. Liegler, J. Alexander, P. Cresswell, I. Goldfine, and R. S. Goodenow. An analysis of insulin recptor expression and binding on MHC class I positive and negative human lymphoblastoid cells. J. Immunol. 145,1788-93 (1990)
26. T. Liegler, J. Szollosi.W. Hyun, and R. S. Goodenow. Proximity measurements between H-2 antigens and the insulin receptor by fluorescence energy transfer: Evidence that a close association does not influence insulin binding. Proe. Natl. Acad. Sci. USA 88,6755-9 (1991)
27. C I Philpott, R A. Rahman, N. Kenny.T. R. Londo, R. M. Young, B. G. Barisas, and D. A. Roess. Rotational dynamics of luteinizing hormone receptors and MHC class I antigens on murine Leydig cells. Biochim. Biophys. Acta. 1235,62-8(1995)
28. M. T. Heemels and H. Ploegh. Generation.Translocation, and Presentation of MHC Class I-restricted Peptides. Annu. Rev. Biochem. 64,463-91 (1995)
29. R P. Babbitt, P. M. Allen, G Matsueda, E Haber, and E R. Unanue. Binding of immunogenic peptides to la histocompatibility molecules. Nature 317,359-61 (1985)
30. S. Buus, S. Colon, C Smith, I H. Freed, C Miles, and H. M. Grey. Interaction between a "processed" ovalbumin peptide and la molecules. Proc. Natl. Acad. Sci. USA 83,3968-71 (1986)
31. S. Buus, A. Seite, S. M. Colon, C Miles, and H. M. Grey.The relation between major histocompatibility complex (MHQ restriction and the capacity of la to bind immunogenic peptides. Science 235,1353-8 (1987)
32. Y. Ebina, L. Ellis, K. Jamagin, M. Edery, L. Graf, E Clauser, J. H. Ou, F. Masiarz,Y.W Kan, I. D. Goldfine, et aL The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. CelL 40,747-58 (1985)
33. Y Ebina, M. Edery, L. Ellis, D. Standring, J. Beaudoin, R. A. Roth, and W. J. Rutter. Expression of a functional human insulin receptor from a cloned cDNA in Chinese hamster ovary cells. Proc. Natl. Acad. Sci. USA 82,8014-8 (1985)
34. A. Ullrich, J R. Bell, EY. Chen, R. Herrera, L. M. Petruzzelli.T. J. Dull, A. Gray, L, Coussens.Y. C. Liao, M. Tsubokawa, et aL Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature. 313,756-61 (1985)
35. K. Christiansen, J. Tranum-Jensen, J. Carlsen, and J. Vinten. A model for the quaternary structure of human placental insulin receptor deduced from electron microscopy. Proc Natl. Acad. Sci. USA 88,249-52 (1991)
36. 25Insulins. Photoactivatable analogues that quantitatively cross-link, radiolabel, and activate the insulin receptor. J. Biol. Chem. 268,4085-91 (1993)
37. M. Joly, A. Kazlauskas, F. S. Fay, and & Con-era. Disruption of PDGF Receptor Trafficking by Mutation oflts PI-3 Kinase Binding Sites. Science 263,684-7 (1994)
38. W. J. Fantl, D. E. Johnson, and L.T.Williams. Signalling by Receptor Tyrosine Kinases. Annu. Rev. Biochem. 62,453-81 (1993)
39. M. A. Lemmon and J. Schlessinger. Regulation of signal transduction and signal diversity by receptor oligomerization. Trends. Biochem. Sci. 19,459-63 (1994)
40. M. F.White and C R. Kahn.The Insulin Signaling System. J. Biol. Chem. 269,14(1994)
41. B. Zhang and R. A. Roth. The Insulin Receptor-related Receptor. Tissue Expression, Ligand Specificity, and Signaling Capabilities. J. Biol. Chem. 267,18320-8(1992)
42. S. R. Hubbard, LAVei, L. Ellis, and W. A. Hendrickson. Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature, 372,746-54 (1994)
43. D. R. Knighton, J. H. Zheng, L. F.Ten Eyck, N. H. Xuong, S. S.TayIor, and J. M. Sowadski. Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science. 253,41420(1991)
44. D. R. Knighton, J. H. Zheng, L. F.Ten Eyck,V. A. Ashford, K. H. Xuong, S. S. Taylor, and I M. Sowadski. Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science. 253,407-14 (1991)
45. J. Lee, P. F. Pilch, S. E. Shoelson, and S. F. Scarlata. Conformational changes of the insulin receptor upon insulin binding and activation as monitored by fluorescence spectroscopy. Biochemistry 36,2701-8 (1997)
46. A. L. Frattali, J. L. Treadway, and J. E. Pessin. Transmembrane Signaling by the Human Insulin Receptor Kinase. J. Biol. Chem. 267,19521-8 (1992)
47. J. Lee, T. O Hare, P. F. Pilch, and S. E. Shoelson. Insulin Receptor Autophosphory lation Occurs Asymmetrically. J. Biol. Chem. 268,4092-8 (1993)
48. P. Dent, A. Lavoinne, S. Nakielny, F. B. Caudwell, P. Watt, and P. Cohen. The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle. Nature 348,302-8 (1992)
49. M. J. Quon, A. J. Butte, M. J. Zamowski, G. Sesti, S. Cushman, and S. I.Taylor. Insulin Receptor Substrate 1 Mediates the Stimulatory Efect of Insulin on GLUT4 Translocation in Transfected Rat Adipose Cells. J. Biol. Chem. 269,27920-4(1994)
50. D.W. Rose, A. R. Saltiel, M. Majumdar, S. J. Decker, and J. M. Olefsky. Insulin receptor substrate 1 is required for insulin-medated mitogenic signal transduction. Proc. Natl. Acad. Sci. USA 91,797-801 (1994)
51. G. E. Lienhard. Life without the 1RS. Nature 372,128-9(1994)
52. H.Tamemoto,T. Kadowaki, K.Tobe,T.Yagi, H. Sakura.T. Hayakawa.Y.Terauchi, K. Ueki,Y Kaburagi, and S. Satoh. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372,182-6 (1994)
53. E. Araki, M. A. Lipes, M.-E Patti, J. C. Bruning, B. Haag III, R. S. Johnson, and C R. Kahn. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature, 372,186-90 (1994)
54. A. J. Morris, S. S. Martin.T. Haruta, J. G. Nelson, P.VoIlenweider.T. A. Gustafson, M. Mueckler, D.W. Rose, and J. M. Olefsky. Evidence for an insulin receptor substrate 1 independent insulin signaling pathway that mediates insulin-responsive glucose transporter (GLUT4) translocation. Proc. Natl. Acad. Sci. USA 93,8401-6 (1996)
55. A. Krook, D. E. Moller, K. Dib, and S. O. Rahilly.Two naturally occurring mutant insulin receptors phosphorylate insulin receptor substrate-I (IRS-1) but fail to mediate the biological effects of insulin. Evidence that IRS-1 phosphorylation is not sufficient for normal insulin action. J. Biol. Chem. 271,7134-40 (1996)
56. T. Sasaoka, D.W. Rose, B. H. Jhun, A. R. Saltiel, B. Draznin, and l M. Olefsky. Evidence for a Functional Role of She Proteins in Mitogenic Signaling Induced by Insulin, Insulin-like Growth Factor-1, and Epidermal Growth Factor. J. Biol. Chem. 269,13689-94 (1994)
57. K.Yonezawa, A. Ando,Y. Kaburagi, R. Yamamoto-Honda, T. Kitamura, K. Hara, M. Nakafuku.Y. Okabayashi.T. Kadowaki, Y. Kaziro, and M. Kasuga. Signal Transduction Pathways from Insulin Receptors to Ras. J. Biol. Chem. 269,4634-40(1994)
58. L, Bonfini, E Migliaccio, G. Pelicci, L. Lanfrancone, and P. G. Pelicci. Not all She s roads lead to Ras. Trends. Biochem. Sci. 21,257-61 (1996)
59. M. E. Patu, X. J. Sun, J. C. Bruening, E Araki, M. A. Lipes, M. F.White, and C R. Kahn. 4PS/insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice. J. Biol. Chem. 270,24670-3 (1995)
60. M. J. Eck, S. Dhe-Paganon,T.Trub, R.T. Nolle, and S. E. Shoelsoa Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor. Cell 85,695-705 (1996)
61. A. D. Keegan, K. Nelms, M. F.White, L-M.Wang, IR Pierce, and W E Paul. An IL-4 Receptor Region Containing an Insulin Receptor Motif Is Important for IL4-Mediated IRS-1 Phosphorylation and Cell Growth. Cell 76,811-20 (1994)
62. CW.Ward, K. H. Gough, M. Rashke, S. S.Wan, G.Tribbick, and J.Wang. Systematic mapping of potential binding sites for She and Grb2 SH2 domains on insulin receptor substrate-1 and the receptors for insulin, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor. J. Biol. Chem. 271,5603-9(1996)
63. M. M. Zhou, B. Huang, ET. Olejniczak, R. P. Meadows, S. B. Shuker, M. Miyazaki.T. Trub, S. E. Shoelson, and S.W. Fesik. Structural basis for IL-4 receptor phosphopeptide recognition by the IRS-1 PTB domain. Nat. Struct. Biol. 3,388-93 (1996)
64. X. J. Sun, S. Pons.T. Asano, M. G. Myers, Jr., E Glasheen, and M. F.White.The Fyn tyrosine kinase binds Irs-1 and forms a distinct signaling complex during insulin stimulation. J. Biol. Chem. 271,10583-7 (1996)
65. C-H. Lee,W Li, R. Nishimura, M. Zhou, A. G. Batzer, M. G. Myers Jr., M. F. White, J. Schlessinger, and E Y Skolnik. Nek associates with the SH2 domaindocking protein IRS-1 in insulin-stimulated cells. Proc. Nail. Acad. Sci. USA 90,11713-7(1993)
66. R. B. Birge and H. Hanafusa. Closing in on SH2 Specificity. Science 262,1522-4 (1993)
67. G. B. Cohen, R. Ren, and D. Baltimore. Modular binding domains in signal transduction proteins. Cell 80,237-48 (1995)
68. P. A. Staubs, D. R. Reichart, A. R. Saltiel, K. L, Milarski, H. Maegawa, P. Berhanu, J. M. Olefsky, and B. L. Seely. Localization of the Insulin Receptor Binding Sites for the SH2 Domain Proteins p85, Syp, and GAP. J. Biol. Chem. 269,27186-92(1994)
69. L.-M. Chuang, S. F. Hausdroff, M. G. Myers, M. F.White, M. J. Birnbaum, and C R. Kahn. Interactive Roles of Ras, Insulin Receptor Substrate-1, and Proteins with Src Homology-2 Domains in Insulin Signaling in Xenopus Oocytes. J. Biol. Chem. 269,27645-9 (1994)
70. P. De Camilli, S. D. Emr, P. S. McPherson, P. Novick,Phosphoinositides as Regulators in MembraneTraffic. Science (1996). 271:1533-1539.
71. K. H. Holt, L. Olson.W. E. Moye-Rowley, and J. E. Pessin. Phosphatidylinositol 3-kinase activation is mediated by high-affinity interactions between distinct domains within the pllO and p85 subunits. MoL Cell. Biol. 14,42-9 (1994)
72. R. Dhand, K. Hara, I. Hues, B. Bax, I. Gout, G. Panayotou, M. J. Fry, K. Yonezawa, M. Kasuga, and M. DWaterfield. PI 3-kinase: structural and functional analysis of intersubunit interactions. EMBO J. 13,511-21 (1994)
73. K. Lam, C L. Carpenter, N. B. Ruderman, J. C. Friel, and K. L. Kelly. The phosphatidylinositol 3-kinase serine kinase phosphorylates IRS-1. Stimulation by insulin and inhibition by Wortmannin. J. Biol. Chem. 269,20648-52 (1994)
74. K. L. Kelly, N. B. Ruderman, and K. S. Chen. Phosphatidylinositol-3-Kinase in Isolated Rat Adipocytes. J. Biol. Chem. 267,3423-8 (1992)
75. K. S. Chen, J. C. Friel, and N. B. Ruderman. Regulation of phosphatidylinositol 3-kinase by insulin in rat skeletal muscle. Am. J. Physiol. 265,E736-42 (1993)
76. B. Cheatham, C IVlahos, L. Cheatham, L.Wang, J. Blenis, and C R. Kahn. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol. Cell. Biol. 14,4902-11 (1994)
77. K. Hara, K.Yoneawa, H. Sakaue, A. Ando, K. Kotani,T. Kitamura,Y. Kitamura, H. Ueda, L. Stephens, T. R. Jackson, P. T. Hawkins, R. Dhand, A. E. Clark, G. D. Holman, M. D. Waterfield, and M. Kasuga. 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proc. Natl. Acad. Sci. USA 91,7415-9 (1994)
78. T. Okada.Y Kawano,T. Sakakibara, O. Hazeki, and M. Ui. Essential Role of Phosphatidylinositol 3-Kinase in Insulin-induced Glucose Transport and Antilipolysis in Rat Adipocytes. J. Biol. Chem. 269,3568-73 (1994)
79. C K. Sung,V. Sanchez-Margalet, and I. D. Goldfine. Role of p85 Subunit of Phosphatidylinositol-3-kinase as an Adaptor Molecule Linking the Insulin Receptor, p62, and GTPase-activating Protein. J. Biol. Chem. 269,12503-7 (1994)
80. W. Zhang, J. D. Johnson, and W. J. Rutter. Association and phosphorylationdependent dissociation of proteins in the insulin receptor complex. Proc. Natl. Acad. Sci. USA 90,11317-21 (1993)
81. G.W. Booker, I. Gout, A. K. Downing, P. C. Driscoll, J. Boyd, M. D. Waterfield, and I. D. Campbell. Solution Structure and Ligand-Binding Site of the SH3 Domain of the p85 Subunit of Phosphatidylinositol 3-Kinase. Cell 73,813-22 (1993)
82. I. Gout, R. Dhand, I. D. Hues, M. J. Fry, G. Panayotou, P. Das, O.Truong, N. F. Totty, I Hsuan, G. W. Booker, I. D. Campbell, and M. D. Waterfield. The GTPase Dynamin Binds to and Is Activated by a Subset of SH3 Domains. Cell 75,25-36(1993)
83. H. Miki, K. Miura, K. Matuoka.T. Nakata, N. Hirokawa, S. Orita, K. Kaibuchi, Y Takai, and T. Takenawa. Association of Ash/Grb-2 with Dynamin through the Src Homology 3 Domain. J. Biol. Chem. 269,5489-92 (1994)
84. H. Yu, J. K. Chen, S. Feng, D. C. Dalgarno, A.W Brauer, and S. L. Schreiber. Structural Basis for the Binding of Proline-Rich Peptides to SH3 Domains. Cell 76,933-45(1994)
85. W A. Lim, F. M. Richards, and R. O. Fox. Structural determinants of peptidebinding orientation and of sequence specificity in SH3 domains. Nature 372,375-9 (1994)
86. C M. Pleiman,W. M. Hertz, and J. C. Cambier. Activation of Phosphatidylinositol-3 Kinase by Src-Family Kinase SH3 Binding to the p85 Subunit. Science 263,1609-12(1994)
87. E Y. Skolnik, C-H. Lee, A. Batzer, L. M.Vicenti, M. Zhou, R. Daly, M. J. Myers, J. M. Backer, A. Ullrich, M. F. White,S, and l Schlessingcr.The SH2/ SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and She: implications for insulin control of ras signalling. EMBO J. 12,1929-36(1993)
88. K. Baltensperger, L. M. Kozma, A. D. Chemiack, J. K. Klarlund, A. Chawla, U Banerjee, and M. P. Czech. Binding of the Ras Activator Son of Sevenless to Insulin Receptor Substrate-1 Signaling Complexes. Science 260,1950-2 (1993)
89. EY. Skolnik, A. Batzer, N. Li, C-H. Lee, E Lowenstein, M. Mohammadi, B. Margolis, and J. Schlessinger. The Function of GRB2 in Linking the Insulin Receptor to Ras Signaling Pathways. Science 260,1953-5 (1993)
90. D. R. Lowy and B. M.Willumsen. Function and Regulation of Ras. Annu. Rev. Biochem. 62,851-91 (1993)
91. I. Path, F. Schweighofier, I. Key, M.-G Multon, J. Boiziau, M. Duchesne, and B. Tocque. Cloning of a Grb2 Isoform with Apoptotic Properties. Science 264,971-4(1994)
92. T. J. O Neill, D.W. Rose,T. S. Pillay, K. Holla, J. M. Olefsky, and T. A. Gustafson. Interaction of a GRB-IR splice variant (a human GRB10 homolog) with the insulin and insulin-like growth factor I receptors. Evidence for a role in mitogenic signaling. J. Biol. Chem. 271,22506-13 (1996)
93. G. S. Feng,Y. B. Ouyang, D. P. Hu, Z. Q. Shi, R. Gentz, and I A. Ni. Grap is a novel SH3-SH2-SH3 adaptor protein that couples tyrosine kinases to the Ras pathway. J. Biol. Chem. 271,12129-32 (1996)
94. M. Holgado-Madruga, D. R. Emlet, D. K. Moscatello, A. K. Godwin, and A. J. Wong. A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature 379,560-4 (1996)
95. N. Ringstad.Y Nemoto, and P. De Camilli. The SH3p4/Sh3p8/SH3pl3 protein family: binding partners for synaptojanin and dynamin via a Grb2-like src homology 3 domain. Proc. Natl. Acad. Sci. USA 94,8569-74 (1997)
96. D. D. Schlaepfer, S. K. Hanks, T. Hunier, and P. van der Geer. Integrinmediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 372,786-91 (1994)
97. F. Hofer, S. Fields, C Schneider, and G. S. Martin. Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. Proc. Natl. Acad. Sci USA 91,11089-93(1994)
98. Y. Hosomi, K. Shii.W. Ogawa, H. Matsuba, M.Yoshida.Y. Okada, K.Yokono, M. Kasuga, S. Baba, and R. A. Roth. Characterization of a 60-kilodalton Substrate of the Insulin Receptor Kinase. J. Biol. Chem. 269,11498-502 (1994)
99. A. D. Cherniack, Jl K. Klarlund, and M. P. Czech. Phosphor) lation of the Ras Nucleotide Exchange Factor Son of Sevenless by Mitogen-activated Protein Kinase. J. Biol. Chem. 269,4717-20 (1994)
100. G O'Brien. Missing Link in Insulin's Path to Protein Production. Science 266,542-3(1994)
101. G G. Proud. Turned on by insulin. Nalure 371,747-8 (1994)
102. L, A. Feig. The Many Roads That Lead to Ras. Science 260,767-8 (1993)
103. J. Marx. Forging a Path to the Nucleus. Science 260,1588-90 ( 1993)
104. A. Hall. A Biochemical Function for Ras - At Last. Science 264,1413-4 (1994)
105. B. H. Jhun, J. L. Meinkoth, J W Leitner, B. Draznin, and I M. Olefsky. Insulin and Insulin-like Growth Factor-1 Signal Transduction Requires p21ras. J. Biol. Chem. 269,5699-704 (1994)
106. S.-I Kim and C R. Kahn. Insulin Stimulates Phosphor)lation of c-Jun, c-Fos, and Fbs-related Proteins in Cultured Adipocytes. 1 BioL Chem. 269,11887-92 (1994)
107. J. M. Kyriakis, P. Banerjee, E Nikolalali.T. Dai, E A. Rubie, M. F. Ahmad, JAvruch, and J. R.Woodgett.The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369,156-60 (1994)
108. T. A. I Haystead, G M. M. Haystead, C Hu,T.-A. Lin, and J. G. Lawrence Jr. Phosphorylation of PHAS-1 by Mitogen-Aclivated Protein (MAP) Kinase. J. Biol. Chem. 269,23185-91 (1994)
109. T.-A. Lin, X. Kong.T. A. J. Haystead, A. Pause, G. Belsham, N. Sonenberg, and J. G. Lawrence Jr. PHAS-I as a Link Between Mitogen-Activated Protein Kinase and Translation Initiation. Science 266,653-6 (1994)
110. A. Pause, G. J. Belsham, A.-G Gingras, O. Donze,T.-A. Lin, J. G. Lawrence Jr., and N. Sonenberg. Insulin-dependent slimulalion of prolein synthesis by phosphorylalion of a regulalor of 5'-cap function. Nature 371,762-7 (1994)
111. S. A. Moodie, B. M.Willumsen, M. J.Weber, and A.Wolfman. Complexes of Ras.GTP with Raf-1 and Mitogen-Activated Protein Kinase Kinase. Science 260,1658-61 (1994)
112. X.-f. Zhang, J. Settleman, J. M. Kyriakis, E. Takeuchi-Suzuki, S. J. Elledge, M. S. Marshall, J. T. Bruder, U. R. Rapp, and J. Avruch. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1. Nature 364,308-13 (1993)
113. P. H. Warne, P. R.Vicinia, and J. Downward. Direcl interaction of Ras and the amino-terminal region of Raf-1 in vitro. Nature 364,352-5 (1993)
114. B. Hallberg, S. I. Rayter, and J. Downward. Interaction of Ras and Raf in Intact Mammalian Cells upon Extracellular Stimulation. Jl BioL Chem. 269,39136 (1994)
115. G. Daum, I. Eisenmann-Tappe, H.-W. Fries, I Troppmair, and U. R. Rapp. The ins and outs of Raf kinases. Trends Biochem. Sci. 19,474-80 (1994)
116. C. J. Marshall. Raf gels it together. Nature 383,127-8 (1996)
117. Z. Luo, G. Tzivion, P. J. Belshaw, DVawas, M. Marshall, and J. Avruch. Oligomerization activates c-Raf-1 through a Ras-dependent mechanism. Nature 383,181-5 (1996)
118. D. Stokoe, S. G. MacDonald, K. Cadwallader, M. Symons, and l F. Hancock. Aclivalion of Raf as a Result of Recruitment to the Plasma Membrane. Science 264,1463-7(1994)
119. M.Wartman and R. J. Davis.The Native Structure of the Activated Raf Protein Kinase Is a Membrane-bound Multi-subunit Complex. J. Biol. Chem. 269,6695-701 (1994)
120. G M. Crews and R. L. Erikson. Extracellular Signals and Reversible Protein Phosphorylaion: What to Mekof It All. Cell 74,215-7 (1993)
121. D. A. Hughes, A. Ashworth, and G J. Marshall. Complementation of byrl in fission yeast by mammalian MAP kinase kinase requires coexpression of Raf kinase. Nature 364,349-52 (1993)
122. A. Porras, K. Muszynski, U R. Rapp, and E Santos. Dissocialion between Activation of Raf-1 Kinase and the 42-kDa Mitogen-activated Protein Kinase/90kDa S6 Kinase (MAPK/RSK) Cascade in the Insulin/Ras Pathway of Adipocyte Diflerenliation of 3T3 LI Cells. J. Biol. Chem. 269,12741-8 (1994)
123. C. M. M. Haystead, P. Gregory, A. Shirazi, P. Fadden, C Mosse, P. Dent, and T. A. J. Haystead. Insulin Activates a Novel Adipocyte Mitogen-activated Protein Kinase Kinase KinaseThat Shows Rapid Phasic Kinetics and Is Distinct from c-Raf. J. Biol. Chem. 269,12804-8 (1994)
124. F. Zhang, A. Strand, D. Robbins, M. K.Cobb, and E J. Goldsmith. Atomic structure of the Map kinase ERK2 at 23 Aresolution. Nature 367,704-11 (1994)
125. B. Derijard, J. Raingeaud.T. Barret, I.-H. Wu, J. Han, R. J. Ulevitch, and R. J. Davis. Independent Human MAP Kinase Signal Transduction Pathways Denned by MEK and MKK Isoforms. Science 267,682-5 (1995)
126. B. M.T. Burgering and J. L. Bos. Regulation of Ras-mediated signalling: more than one way to skin a cat.Trends. Biochem. Sci. 20,18-22 (1995)
127. M. H. Gelb. Protein prenylation, et cetera: Signal transduction in two dimensions. Science 275,1750-1 (1997)
128. R. J. Resnick and L. Tomaska. Stimulation of yeast adenyryl cyclase activity by lysophospholipids and fatty acids. J. Biol. Chem 269,32336-41 (1994)
129. D. A. Cross, D R. Alessi, P. Cohen, M. Andjelkovich, and R A. Hemmings. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase R Nature 378,785-9(1995)
130. D. R. Alessi, M. Andjelkovic, B. Caudwell, P. Cron, N. Morrice, P. Cohen, and R A. Hemmings. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBOJ. 15,6541-51 (1996)
131. D. R. Alessi, S. R. James, C P. Dowries, A. B. Hohnes, P. R. Gaflhey, C R Reese, and P. Cohen. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr. Biol. 7,261-9(1997)
132. M. J. Brady, i. A. Printen, C C Mastick, and A. R. SaltieL Role of ProteinTargeting to Glycogen (PTG) in the Regulation of Protein Phosphatase-1 Activity. 1 Biol. Chem. 272,20198-204 (1997)
133. J. A. Printen, M. J. Brady, and A. R. SaltieL PTG, a protein phosphatase 1-binding protein with a role in glycogen metabolism. Science 275,1475-8 (1997)
134. K.M.Waltoand J. E. Dixon. ProteinTyrosinePhosphatases. Annu. Rev.Biochem. 62,101-20 (1993)
135. L. J. Mauro and J. E. Dixon. 'Zip' codes direct intracellular protein tyrosine phosphatases to the correct cellular address. Trends. Biochem. Sci. 19,151-155c (1994)
136. H. Sun and N. K. Tonks. The coordinated action of protein tyrosine phosphatases and kinases in cell signaling. Trends. Biochem. Sci. 19,480-5 (1994)
137. K. A. Kenner, E Anyamvu, J. M. Olefsky, and J. Kusari. Protein-tyrosine phosphatase IB is a negative regulator of insulin- and insulin-like growth factor-Istimulaled signaling. J. Biol. Chem. 271,19810-6 (1996)
138. T. Uchida.T. Matozaki.T. Noguchi.T.Yamao, K. Horita.T. Suzuki.Y. Fujioka, C Sakamoto, and M. Kasuga. Insulin Stimulates the Phosphorylation of Tyr538 and the Catalytic Activity of PTP1C, a Protein Tyrosine Phosphalase with Src Homology-2 Domains. J. Biol. Chem. 269,12220-8 (1994)
139. S. SugimotoJ. IWandless, S. E. Shoelson, R. G. Ned, and C. T.Walsh. Activation of the SH2-containing ProteinTyrosine Phosphatase, SH-PTP2, by Phosphotyrosinecontaining Peptides Derived from Insulin Receptor Substrate-1.1 Biol Chem. 269,13614-22(1994)
140. D. Morrison. 14-3-3: Modulators of Signaling Proteins? Science 266,56-7 (1994)
141. H. Fu, K. Xia, D. C. Pallas, C. Cui, K. Conroy, R. P. Narsimhan, H. Mamon, R. J. Collier, and T. M. Roberts. Interaction of the Protein Kinase Raf-1 with 14-33 Proteins. Science 266,126-9 (1994)
142. G.W Reuther, H. Fu, L D. Cripe, R. J. Collier, and A. M. Pendergast. Association of the Protein Kinases c-Bcr and Bcr-Abl with Proteins of the 14-3-3 Family. Science 266,129-33 (1994)
143. J. Lee, S. E. Shoelson, and P. F. Pilch. Intermolecular phosphorylation between insulin holoreceptors does not stimulate substrate kinase activity. J. Biol. Chem. 270,31136-40(1995)
144. A. M. Honegger, R. M. Kris, A. Ullrich, and J. Schlessinger. Evidence that autophosphoryiation of solubilized receptors for epidermal growth factor is mediated by intermolecular cross-phosphorylation. Proc. Natl. Acad. Sci. USA 86,925-9 (1989)
145. D. Accili, L. Mosthaf, A. Ullrich, and S. LTaylor. A mutation in the Extracellular Domain of the Insulin Receptor Impairs the Ability of Insulin to Stimulate Receptor Autophosphorylation. J. Biol. Chem. 266,434-9 (1991)
146. J. E. Foleyand J. Gliemann. Glucose transport in isolated rat adipose cells. Int. J. Obes. 5,679-84 (1981)
147. G. I. Bell, C F. Burant, J. Takeda, and G. W. Gould. Structure and function of mammalian facilitative sugar transporters. J. Biol. Chem. 268,19161-4 (1993)
148. G. W. Gould and G. D. Holman. The glucose transporter family: structure, function and tissue-specific expression. Biochem. J. 295,329-41 (1993)
149. M. Mueckler, C Caruso, S. A. Baldwin, M. Panico, I. Blench, H. R. Morris.W I Allard, G. E. Lienhard, and H. F. Lodish. Sequence and structure of a human glucose transporter. Science 229,941-5 (1985)
150. R. C. Hresko, M. Kruse, M. Strubc, and M. Mueckler. Topology of the GLUT1 transporter deduced from glycosylation scanning mutagenesis. J. Biol. Chem. 269,20482-8(1994)
151. J. Hshbarg, M. Cheung, F. Czegledy, I Li, P. Iserovich, K. Kuang, J. Hubbard, M. Gamer, O. M. Rosen, D.W Golde, and J. CVera. Evidence that facultative glucose transporters may fold as beta-barrels. Proc. Natl. Acad. Sci. USA 90,11658-62 (1993)
152. S.W. Cowan and J. P. Rosenbusch. Folding pattern diversity of integral membrane proteins. Science 264,914-6 (1994)
153. J. CVera, CI. Rivas, J. Fishbarg, and D.W. Golde. Mammalian facilitative hexosetransporters mediate the transport of dehydroaseorbic acid. Nature 364,7982(1993)
154. S. Satoh, H. Nishimura, A. E. Clark, 1.J. Kozka, S. J. Vannucci, I. A. Simpson, M. J. Quon, S.W. Cushman, and G. D. Holmaa Use of bismannose photolabel to elucidate insulin-regulated GLUT4 subcellular trafficking kinetics in rat adipose cells. Evidence that exocytosis is a critical site of hormone actioa J. Biol. Chem. 268,17820-9 (1993)
155. R. C. Piper, C. Tai, J. Slot, H. Huang, C. Rice, and D. E. James. Dissection of the targeting domains of the insulin-regulatable glucose transporter (GLUT4). J. Cell. Biol. 15,303a(1991)
156. R. C. Piper, C. Tai, J.W. Slot, C. S. Hahn, C. Rice, H. Huang, and D. E. James.The efficient intracelllular sequestration of the insulin-regulatable glucose transporter (GLUT4) is conferred by the N terminus. J. Cell. Biol. 117,729-43 (1992)
157. R. C. Piper, C. Tai, P. Kulesza, S. Pang, D.Warnock, J. Baenzinger, J.W. Slot, H. J. Geuze, C. Puri, and D. E. James. GLUT-4 NH2 terminus contains a phenylalanine-based targeting motif that regulates intracellular sequestration. J. Cell. Biol. 121,1221-32 (1993)
158. R. J. Garippa.T.W Judge, D. E. James, and T. E. McGraw. The amino terminus of GLUT4 functions as an internalization motif but not an intracellular retention signal when substituted for the transferrin receptor cytoplasmic domain. J. Cell. Biol. 124,705-15 (1994)
159. M. P. Czech, A. Chawla, C-WWoon, Buxto, M. Armoni.W.Tang, M. Joly, and S. Corvera. Exofadal epitope-tagged glucose transporter chimeras reveal COOH-terminal sequences governing celllular localization. J. Cell. Biol. 123,127-35 (1993)
160. K. J. Verhey, S. F. Hausdorf, and M. J. Birnbaum. Identification of the carboxy terminus as important for the isoform-specific subcellular targeting of glucose transporter proteins. J. Cell. Biol. 123,137-47 (1993)
161. K. J. Verhy and M. J. Birnbaum. A Leu-Leu sequence is essential for COOHterminal targeting signal of GLUT4 glucose transporter in fibroblasts. J. Biol. Chem. 269,2353-6 (1994)
162. S. Corvera, A. Chawla, R. Chakrabarti, M. Joly, J. Buxton, and M. P. Czech. A double leucine within the GLUT4 glucose transporter COOH-terminal domain functions as an endocytosis signal. J. Cell. Biol. 126,979-89 (1994)
163. P. M. Haney, J.W. Slot, R. C. Piper, D. E. James, and M. Mueckler. Intracellular targeting of of the insulin-regulatable glucose transporter (GLUT4) is isoform specific and independent of cell type. J .Cell. Biol. 114,689-99 (1991)
164. W. M. Canfield, K. F. Johnson, R. D.Ye,W. Gregory, and S. Kornfeld. Localization of the signal for rapid internalization of the bovine cation-independent mannose 6-phosphate/insulin-Iike growth factor-II receptor to amino acids 24-29 of the cytoplasmic tail. J. Biol. Chem. 266,5682-8 (1991)
165. H. J. Chen, J. Remmler, J. C. Delaney, D. J. Messner, and P. Lobel. Mutational analysis of the cation-independent mannose 6-phosphate/insulin-like growth factor II receptor. A consensus casein kinase II site followed by 2 leucines near the carboxyl terminus is important for intracellular targeting of lysosomal enzymes. J. Biol. Chem. 268,22338-46 (1993)
166. L JWardzala, I. A. Simpson, M. M. Rechler, and S.W. Cushman. Potential mechanism of the stimulatory action of insulin on insulin-like growth factor II binding to the isolated rat adipose cell. Apparent redistribution of receptors cycling between a large intracellular pool and the plasma membrane. J. Biol. Chem. 259,8378-83 (1984)
167. K. Suzuki and T. Kono. Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site. Proc. Natl. Acad. Sci. USA 77,2542-5 (1980)
168. L. I. Tanner and G. E. Lienhard. Localization of transferrin receptors and insulin-like growth factor II receptors in vesicles from 3T3-L1 adipocytes that contain intracellular glucose transporters. J. Cell. Biol. 108,1537-45 (1989)
169. C. Livingstone, D. E. James, J. E. Rice, D. Hanpeter, and G.W. Gould. Compartment ablation analysis of the insulin-responsive glucose transporter (GLUT4) in 3T3-L1 adipocytes. Biochem. J. 315,487-95 (1996)
170. D. Hanpeter and D. E. James. Characterization of the intracellular GLUT-4 compartment. Mol. Membr. Biol. 12,263-9 (1995)
171. G. A. Herman, F. Bonzelius, A. M. Cieutat, and R. B. Kelly. A distinct class of intracellular storage vesicles, identified by expression of the glucose transporter GLUT4. Proc. Natl. Acad. Sci. USA 91,12750-4 (1994)
172. G. Baldini, T. Hohl, H. Y. Lin, and H. F. Lodish. Cloning of a Rab3 isotype predominantly expressed in adipocytes. Proc. Natl. Acad. Sci USA 89,5049-52 (1992)
173. C. C. Cain,W. S. Tumble, and G. E. Lienhard. Members of the VAMP family of synaptic vesicle proteins are components of glucose transporter-containingvesicles from rat adipocytes. J. Biol. Chem. 267,11681-4 (1992)
174. C. C. Mastick, R. Aebersold, and G. E. Lienhard. Characterization of a major protein in GLUT4 vesicles. J. Biol. Chem. 269,6089-92 (1994)
175. K.V. Kandror and P. F. Pilch. gpl60, a tissue-specific marker for insulin-activated glucose transport. Proc. Natl. Acad. Sci. USA 91,8017-21 (1994)
176. S. Martin, J. Tellam, C Livingstone, J.W. Slot, G.W Gould, and D. E. James.The glucose transporter (GLUT-4) and vesicle-associated membrane protein-2 (VAMP-2) are segregated from recycling endosomes in insulin-sensitive cells. J. Cell. Biol. 134,625-35 (1996)
177. C. C. Mastick and A. L. Falick. Association of N-ethylmaleimide sensitive fusion (NSF) protein and soluble NSF attachment proteins-alpha and -gamma with glucose transporter-4-containing vesicles in primary rat adipocytes. Endocrinology 138,2391-7 (1997)
178. L. Kozma, K. Baltensperger, J. Klarlund, A. Porras, E Santos, and M. P.Czech. The Ras signaling pathway mimics insulin action on glucose transporter translocation. Proc. Natl. Acad Sci. USA 90,4460-4 (1993)
179. S. P. Bessman, C Mohan, and I. Zaidise. Intracellular site of insulin action: Mitochondrial Krebs cycle. Proc. Natl. Acad. Sci. USA 83,5067-70 (1986)
180. D. F. Lazar, J. J. Knez, M. E. Medof, P. Cuatrecasas, and A. R. Saltiel Stimulation of glycogen synthesis by insulin in human erythroleukemia cells requires the synthesis of glycosyl-phosphatodylinositol. Proc. Natl. Acad. Sci. USA 91,9665-9(1994)
181. R. A. Heller-Harrison, M. Morin, A. Guilherme, and M. P. Czech. Insulinmediated targeting of phosphatidylinositol 3-kinase to GLUT4- containing vesicles. 3. Biol. Chem. 271,10200-4 (1996)
182. B.Vanhaesebroeck, S. J. Leevers, G. Panayotou, and M. DWaterfield. Phosphoinosiude 3-kinases: a conserved family of signal transducers. Trends Biochem. Sci. 22,267-72 (1997)
183. P. Chardin, S. Paris, B. Antonny, S. Robineau, S. Beraud-Dufour, C. L. Jackson, and M. Chabre. A human exchange factor for ARF contains Sec7- and pleckstrin-homology domains. Nature 384,481-4 (1996)
184. J. K. Klarlund, A. Guilherme, J. J. Holik, J.V.Virbasius, A. Chawla, and M. P. Czech. Signaling by phosphoinositide-3,4,5-trisphosphate through proteins containing pleckstrin and Sec7 homology domains. Science 275,1927-30 (1997)
185. A. A. Fedorov, K. A. Magnus, M. H. Graupe, E. E. Lattman,T. D. Pollard, and S. C. Alma X-ray structures of isoforms of the actin-binding protein profilin that differ in their affinity for phosphatidylinositol phosphates. Proc. Natl. Acad. Sci. USA 91,8636-40 (1994)
186. R. D. Burgoyne. Phosphoinositides in vesicular traffic. Trends. Biochem. Sci. 19,55-7(1994)
187. H.Voliovitch, D. G. Schindler.Y. R. Hadari, S. I.Taylor, D. Accili, and Y. Zick. Tyrosine phosphorylation of insulin receptor substrate-1 in vivo depends upon the presence of its pleckstrin homology region. J. Biol. Chem. 270,18083-7 (1995)
188. A. D. Kohn, K. S. Kovacina, and R. A. Roth. Insulin stimulates the kinase activity of RAC-PK, a pleckstrin homology domain containing ser/thr kinase. EMBOJ. 14,4288-95 (1995)
189. C R. Artalejo, M. A. Lemmon, J. Schlessinger, and H. C. Palfrey. Specific role for the PH domain of dynamin-1 in the regulation of rapid endocytosis in adrenal chromaffin cells. EMBO116,1565-74 (1997)
190. M. A. Lemmon, K. M. Ferguson, and J. Schlessinger. PH domains: diverse sequences with a common fold recruit signaling molecules to the cell surface. Cell 85,621-4 (1996)
191. M. A. Lemmon, K. M. Ferguson, R. O Brien, P. B. Sigler, and J. Schlessinger. Specific and high-affinity binding of inositol phosphates loan isolated pleckstrin homology domain. Proc. Natl. Acad. Sci. USA 92,10472-6 (1995)
192. D. O. Morgan and R.A. Roth. Acute insulin action requires insulin receptor kinase activity: Introduction of an inhibitory monoclonal antibody into mammalian cells blocks the rapid effects of insulia Proc. Natl. Acad. Sci. USA 84,41-5 (1987)
193. F. Grigorescu.V. Herzberg, G. King, M. Meistas, J. Elders,T. Frazer, and C R. Kahn. Defects in insulin binding and autophosphorylation of erythrocyte insulin receptors in patients with syndromes of severe insulin resistance and their parents. J. Clin. Endocrinol. Metab. 64,549-56 (1987)
194. T. Kadowaki, H. Kadowaki, M. M. Rechler, M. Serrano Rios, J. Roth, P. Gorden, and S. I.Taylor. Five mutant allcles of the insulin receptor gene in patients with genetic forms of insulin resistance. J. Clin. Invest. 86,254-64 (1990)
195. T. Kadowaki, H. Kadowaki, and S. I.Taylor. A nonsense mutation causing decreased levels of insulin receptor mRNA: detection by a simplified technique for direct sequencing of genomic DNA amplified by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 87,658-62 (1990)
196. D. E. Moller, A.Yokota, M. F.White, A. G. Pazianos, and I S. Flier. A naturally occurring mutation of insulin receptor alanine 1134 impairs tyrosine kinase function and is associated with dominantly inherited insulin resistance. J. BioL Chem. 265,14979-85 (1990)
197. D. E. Moller, H. Benecke, and J. S. Flier. Biologic activities of naturally occurring human insulin receptor mutations. Evidence that metabolic effects of insulin can be mediated by a kinase-deficient insulin receptor mutant. J. Biol. Chem. 266,10995-1001 (1991)
198. D. E. Moller, O. Cohen,Y. Yamaguchi, R. Assiz, F. Grigorescu, A. Eberle, L. A. Morrow, A. C Moses, and J. S. Flier. Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Diabetes. 43,247-55 (1994)
199. B. J. Goldstein and C R. Kahn. Insulin receptor messenger ribonucleic acid sequence alteration detected by ribonuclease cleavage in patients with syndromes of insulin resistance. J. Clin. Endocrinol. Metab. 69,15-24 (1989)
200. R. S. Haber and S. P. Weinstein. Role of Glucose Transporters in Glucocorticoid-Induced Insulin Resistance. Diabetes 41,728-35 (1992)
201. B. a. Leighton.GIS. Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitra Nature 335,632-5 (1988)
202. D. K. Richardson and M. P. Czech. Primary role of decreased fatty acid synthesis in insulin resistance of large adipocytes. Am. J. PhysioL 234,182-9 (1978)
203. D. E James and R. C Piper. Insulin Resistance, Diabetes,and the Insulin-regulated Trafficking of GLUT4. J. Cell. Biol. 1123-6 (1994)
204. S. P.Weinstein.T. Paquin, A. Pritsker, and R. S. Haber. Glucocorticoid-induced insulin resistance: dexamethasone inhibits the activation of glucose transport in rat skeletal muscle by both insulin- and non-insulin-related stimuli. Diabetes. 44,441-5(1995)
205. C C Cain,W S.Trimble, and G. E Lienhard. Members of the VAMP family of synaptic vesicle proteins are components of glucose transporter-containingvesicles from rat adipocytes. J. Biol. Chem. 267,11681-4 (1992)
206. H. Shibata,Y Suzuki, W. Omata, S. Tanaka, and I. Kojima. Dissection of GLUT4 recycling pathway into exocytosis and endocytosis in rat adipocytes. Evidence that GTP-binding proteins are involved in both processes. J. Biol. Chem. 270,11489-95 (1995)
207. H. Shibata.W. Omata,Y. Suzuki, S. Tanaka, and I. Kojima. A Synthetic Peptide Corresponding to the RaW Hypervariable Carboxyl-terminal Domain Inhibits Insulin Action on Glucose Transport in Rat Adipocytes. J. Biol. Chem. 271,9704-9(1996)
208. M. N. Bortoluzzi, M. Cormont, N. Gautier, E van Obberghen, and Y. Le Marchand-Brustel. GTPase activating protein activity for RaM is enriched in the plasma membrane of 3T3-L1 adipocytes. Possible involvement in the regulation of Rab4 subcellular localization. Diabetologia 39,899-906 (1996)
209. C Reynet and C R. Kahn. Rad: A Member of the Ras Family Overexpressed in Muscle of Type II Diabetic Humans. Science 262,1441-4 (1993)
210. J. S. Flier. The Adipocyte: Storage Depot or Node on the Energy Information Superhighway? Cell 80,15-8 (1995)
211. A. Simpson and S.W. Cushman. Hormonal regulation of mammalian glucose transport. Annu. Rev. Biochem. 55,1059-89 (1986)
212. R. C Honnor, S. Naghshineh, S.W Cushman, J. Wolff, I. A. Simpson, and C Londos. Cholera and pertussis toxins modify regulation of glucose transport activity in rat adipose cells: evidence for mediation of a cAMP-independent process by G-proteins. Cell. Signal 4,87-98 (1992)
213. S. IVannucci, H. Nishimura, S. Satoh, S.W. Cushman, G. D. Holman, and I. A. Sim'pson. Cell surface accessibility of GLUT4 glucose transporters in insulinstimulated rat adipose cells. Modulation by isoprenaline and adenosine. Biochem. 1288,325-30 (1992)
214. T. Kono. Destruction of insulin effector system of adipose tissue cells by proteolytic enzymes. J. Biol. Chem. 244,1772-8 (1969)
215. T. Kono. Destruction and Restoration of the Insulin Effector System of Isolated Fat Cells. J. Biol. Chem. 244,5777-84 (1969)
216. T. Kono and F. W. Barham. Insulin-like effects of trypsin on fat cells. J. Biol. Chem. 246,6204-9 (1971)
217. T. Kono and F.W Barham.The Relationship between the Insulin-binding Capacity of Fat Cells and the Cellular Response to Insulin. J. Biol. Chem. 246,6210-6(1971)
218. G. D. Holman, L. Lo Leggio, and S.W. Cushmaa Insulin-stimulated GLUT4 glucose transporter recycling. A problem in membrane protein subcellular trafficking through multiple pools. J. Biol. Chem. 269,17516-24 (1994)
219. R. Horuk, S. Matthaei, J. M. Olefsky, D. L. Baly, S.W Cushman, and I. A. Simpsoa Biochemical and Functional Heterogenity of Rat Adipocyte Glucose Transporters. J. Biol. Chem. 261,1823-8 (1986)
220. D. L. Bafy and R. Horuk. The biology and biochemistry of the glucose transporter. Biochim. Biophys. Acta 947,571-90 (1988)
221. S. Matthaei.WT. Garvey, R. Horuk.T. P. Huecksteadt, and J. M. Olefsky. Human Adipocyte GlucoseTransport System. Biochemical and functional heterogeneity of hexose carriers. I Clin. Invest. 79,703-9 (1987)
222. R. R. Whitesell, D. M. Regen, and N. A. Abumrad. Evidence for functionally distinct glucose transporters in the basal and insulin-stimulated adipocytes. Biochem. 28,6937-43 (1989)
223. D. E James, R. Brown, I Navarro, and P. F. Pilch. Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein. Nature. 333,183-5 (1988)
224. D. E. James, M. Strube, and M. Mueckler. Molecularcloning and characterization of an insulin-regulatable glucose transporter. Nature. 338,83-7 (1989)
225. Y. Oka.T. Asano,Y. Shibasaki, M. Kasuga.Y. Kanazawa, and F.Takaku. Studies with antipeptide antibody suggest the presence of at least two types of glucose transporter in rat brain and adipocyte. J. Biol. Chem. 263,13432-9 (1988)
226. H. G. Joost.T. M.Weber, S.W. Cushman, and I. A. Simpson. Activity and phosphorylation state of glucose transporters in plasma membranes from insulin-, isoproterenol-, and phorbol ester-treated rat adipose cells. J. Biol. Chem. 262,11261-7 (1987)
227. H. Nishimura, J. Saltis, A. D. Habberfield, N. R Garty, A. S. Greenberg, S. W Cushman, C Londos, and I. A. Simpson. Phosphorylation state of the GLUT4 isoform of the glucose transporter in subfractions of the rat adipose cell: effects of insulin, adenosine, and isoproterenol Proc. Natl. Acad. Sci. USA 88,11500-4 (1991)
228. R. C Piper, D. E James, IW Slot, C Puri, and J. C Lawrence, Jr. GLUT4 phosphorylation and inhibition of glucose transport by dibutyryl cAMP. J. Biol. Chem. 268,16557-63(1993)
229. D. E James, J. Hiken, and J. C Lawrence,Jr. Isoproterenol stimulates phosphory'ation of the insulin-regulatable glucose transporter in rat adipocytes. Proc. Natl. Acad. Sci. USA 86,8368-72 (1989)
230. J. R. Glenney,Jr.,W. S. Chen, C S. Lazar, G. M. Walton, L. M. Zokas, M. G. Rosenfeld, and G. N. Gill. Ligand-induced endocytosis of the EOF receptor is blocked by mutational inactivation and by microinjection of anti-phosphotyrosine antibodies. Cell. 52,675-84 (1988)
231. B. Kublaoui, J. Lee, and P. F. Pilch. Dynamics of signaling during insulin-stimulated endocytosis of its receptor in adipocytes. J. Biol. Chem. 270,59-65 (1995)
232. D. A. McClain. Endocytosis of insulin receptors is not required for activation or deactivation of the hormone response. J. Biol. Chem. 265,21363-7 (1990)
233. A. Ciechanover, A. L. Schwartz, and H. F. Lodish.The asialoglycoprotein receptor internalizes and recycles independently of the transferrin and insulin receptors. Cell. 32,267-75 (1983)
234. F. B. Kraemer, S. A. Sathcr, R Park, C Sztalryd.V. Natu, K. May, II Nishimura, I. Simpson, A. D. Cooper, and S.W. Cushman. Low density lipoprotein receptors in rat adipose cells: subcellular localization and regulation by insulin. J. Lipid. Res. 35,1760-72 (1994)
235. M. K. Bennett and R. H. Scheller. The molecular machinery for secretion is conserved from yeast to neurons. Proc, Natl Acad. Sci. USA 90,2559-63 (1993)
236. T. E Sollner, S.W.Whiteheart, M. Brunner, H. Erdjument-Bromage, S. Geromanos, P.Tempst, and J. E Rothman. SNAP receptors implicated in vesicle targeting and fusion. Nature 362,318-24 (1993)
237. E Rothman and F. T. Wieland. Protein sorting by transport vesicles. Science 272,227-34(1996)
238. E Rothman.The reconstitution of intracellular protein transport in cell-free systems.The Harvey Lectures 86,65-85 (1992)
239. N. Calakos, M. K. Bennett, K. E Peterson,and R. H. Scheller. Protein-Protein Interactions Contributing to the Specificity of Intracellular VesicularTrafficking. Science 263,1146-9 (1994)
240. M. K. Bennett and R. H. Scheller. A molecular description of synaptic vesicle membrane trafficking. Annu. Rev. Biochem. 63:63-100,63-100 (1994)
241. M. Lenhard, M. I. Colombo, and P. D. Stahl. Heterotrimeric GTP-binding proteins (G proteins) and ADP-ribosylation factor (ARF) regulate priming of endosomal membranes for fusion. Arch. Biochem. Biophys. 312,474-9 (1994)
242. C J. Zhang, A. G. Rosenwald, M. CWillingham, S. Skuntz, J. Clark, and R. A. Kahn. Expression of a dominant allele of human ARF1 inhibits membrane traffic in vi%-o. J. Cell Biol. 124,289-300 (1994)
243. C D Souza-Schorey, G. Li, M. I. Colombo, and P. D. Stahl. A Regulatory Role for ARF6 in Receptor-Mediated Endocytosis. Science 267,1175-8 (1995)
244. C Nuoffer and W. E Balch. GTPases: Multifunctional Molecular Switches Regulating Vesicular Traffic. Annu. Rev. Biochem. 63,949-90 (1994)
245. P. Chavrier, I P. Gorvel, E Stelzer, K. Simons, J. Gruenberg, and M. Zerial. Hypervariable C-terminal domain of rab proteins acts as a targeting signal. Nature 353,769-72(1991)
246. P. Gorvel, P. Chavrier, M. Zerial, and J. Gruenberg. rabS controls early cndosome fusion in vitra Cell 64,915-25 (1991)
247. B. Singer Kruger, H. Stenmark, A. Dusterhoft, P. Philippsen, J. S. Yoo, D. Gallwitz, and M. Zerial Role of three rab5-like GTPases, Ypt51p, Ypt52p, and Ypt53p, in the endocytic and vacuolar protein sorting pathways of yeast. J. Cell Biol. 125,283-98 (1994)
248. H. Stenmark, R. G. Parton, O. Steele Mortimer, A. Lutcke, J. Gruenberg, and M. Zerial. Inhibition of rabS GTPase activity stimulates membrane fusion in endocytosis. EMBO J. 13,1287-96 (1994)
249. M. Aridor and W E Balch. Membrane fusion: timing is everything. Nature 383, 220-1 (1996)
250. V. Rybin, O. Ullrich, M. Rubino, K. Alexandrov, I. Simon, M. C Seabra, R. Goody, and M. ZeriaL GTPase activity of RabS acts as a timer for endocytic membrane fusion. Nature 383,266-9 (1996)
251. M. D.Turner, H. Plutner, and W. E Balch. A Rab GTPase is required for homotypic assembly of the endoplasmic reticulum. J. Biol. Chem. 272,13479-83 (1997)
252. S. R. Pfeffer, A. B. Dirac Svejstrup, and T. Soldati. Rab GDP Dissociation Inhibitor: Putting Rab GTPases in the Right Place. J. Biol. Chem. 270,17057-9 (1995)
253. O. Rossetto, G. Schiavo, C Montecucco, B. Poulain, F. Deloye, L. Lozzi, and C C Shone. SNARE motif and neurotoxins. Nature 372,415-6 (1994)
254. S. Yamasaki,Y Hu,T. Binz, A. Kalkuhl, H. Kurazonq,T.Tamura, R. Jahn, E Kandel, and H. Niemann. SynaptobrevinA'esicle-associated membrane protein (VAMP) of Aplysia californica: structure and proteolysis by tetanus toxin and botulinal neurotoxins type D and F. Proc NaU Acad. Sci. USA 91,4688-92 (1994)
255. S.Yamasaki,T. Binz.T. Hayashi, E Szabo, N.Yamasaki, M. Eklund, R. Jahn, and H. Niemann. Botulinum neurotoxin type G proteolyses the Ala81-Ala82 bond of rat synaptobrevin 2. Biochem. Biophys. Res. Commun. 200,829-35 (1994)
256. T. Binz, J. Blasi, S.Yamasaki, A. Baumeister, E Link.T. C Sudhof, R. Jahn, and H. Niemann. Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J. Biol. Chem. 269,1617-20 (1994)
257. Blasi, E R. Chapman, E Link.T. Binz, S. Yamasaki, P. De Camilli,T. C Sudhof, H. Niemann, and R. Jahn. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 365,160-3 (1993)
258. M. Guerre-Millo, G. Baldini, H. F. Lodish, M. Lavau, and S.W. Cushmaa Rab 3D in rat adipose cells and its overexpression in genetic obesity (Zucker fatty rat). Biochem. 1321,89-93 (1997)
259. T. Rowe and W. E Balch. Membrane fusion. Bridging the gap by AAA ATPases. Nature 388,20-1 (1997)
260. H. Kondo, C Rabouille, R. Newman,T. P. Levine, D. Pappin, P. Freemont, and G. Warren. p47 is a cofactor for p97-mediated membrane fusion. Nature 388,758 (1997)
261. J. B. Bock and R. H. Scheller. Protein transport. A fusion of new ideas. Nature 387,133-5 (1997)
262. B. J. Nichols, C Ungermann, H. R. Pclham.W.T. Wickner, and A. Haas. Homotypic vacuolar fusion mediated by t- and v-SNAREs. Nature 387,199-202 (1997)
263. A. R Dirac-Svejstrup,T. Sumizawa, and S. R. Pfeffer. Identification of a GDI displacement factor that releases endosoma] Rab GTPases from Rab-GDL EMBO J. 16,465-72(1997)
264. S. H. Hansen, K. Sandvig, and B. van Deurs.The preendosomal compartment comprises distinct coated and noncoated endocytic vesicle populations. I Cell BioL 113,731-41 (1991)
265. S. H. Hansen, K. Sandvig, and & van Deurs. Molecules internalized by cla-thrin-indcpendent endocytosis are delivered to endosomes containing transferrin receptors. J. Cell. Biol. 123,89-97 (1993)
266. L. L. Carter.T. E Redelmeier, L. A. Woollenweber, and S. L. Schmid. Multiple GTP-binding proteins participate in clathrin-coated vesicle-mediated endocytosis. J. Cell Biol. 120,37-45 (1993)
267. H. C. Lin.T. C Sudhof, and R. G. Anderson. Annexin VI is required for budding of clathrin-coated pits. Cell 70,283-91 (1992)
268. J. Heuser. Effects of cytoplasmic acidification on clathrin lattice morphology. J. Cell. Biol. 108,401-11 (1989)
269. S. H. Hansen, K. Sandvig, and R van Deurs. Clathrin and HA2 adaptors: effects of potassium depletion, hypertonic medium, and cytosol acidification. J. Cell. Biol. 121,61-72 (1993)
270. S. Nathke, I Heuser, A. Lupas, I Stock, C W Turck, and F. M. Brodsky. Folding and trimerization of clathrin subunits at the triskelion hub. Cell 68,899-910 (1992)
271. S. H. Liu, M. LWong, C S. Craik, and F. M. Brodsky. Regulation of clathrin assembly and trimerization denned using recombinant triskelion hubs. Cell. 83,257-67(1995)
272. B. M. F. Pearse. Clathrin and coated vesicles. EMBO J. 6,2507-12 (1987)
273. M. S. Robinson. 100-kD coated vesicle proteins: Molecular heterogeneity and intracellular distribution studied with monoclonal antibodies. I Cell. Biol. 104,887-95(1987)
274. B. M. F. Pearse. Receptors compete for adaptors found in plasma membrane coated pits. EMBO J. 7,3331-6 (1988)
275. S. Ahle, A. Mann, U Eichelsbacher, and E Ungewickell. Structural relationships between clathrin assembly proteins from the Golgi and the plasma membrane. EMBO J. 7,919-29 (1995)
276. M. S. Robinson. Assembly and targeting of adaptin chimaeras in transfected cells. J. Cell. Biol. 123,67-77(1993)
277. F. Simpson, N. A. Bright, M. A. West, L. S. Newman, R. R Darnell, and M. S. Robinsoa A novel adaptor-related protein complex. 1 Cell Biol 133,749-60 (1996)
278. F. Simpson, A. A. Peden, L. Christopoulou, and M. S. Robinson. Characterization of the adaptor-related protein complex, AP-3. J. Cell Biol. 137,835-45 (1997)
279. E C Dell Angelica, H. Ohno, C E Ooi, E Rabinovich, K.W Roche, and J. S. Bonifacino. AP-3: an adaptor-like protein complex with ubiquitous expression. EMBO 116,917-28(1997)
280. B. M. F, Pearse. Assembly of the mannose-6-phosphate receptor into reconstituted clathrin coats. EMBO J. 4,2457-60 (1985)
281. Z. Zhang, R A. DavIetov.T. C Sudhof, and R. G Anderson. Synaptotagmin I is a high affinity receptor for clathrin AP-2: implications for membrane recycling. Cell 78,751-60(1994)
282. A. Sorkin and G. Carpenter. Interaction of activated EOF receptors with coated pit adaptins. Science 261,612-5 (1993)
283. A. Sorkin, M. Mazzotti, T. Sorkina, L. Scotto, and L. Beguinot. Epidermal growth factor receptor interaction with clathrin adaptors is mediated by the Tyr974-containing internalization motif. J. Biol. Chem. 271,13377-84 (1996)
284. R. Heilker, U Manning-Krieg, J. F. Zuber, and M. Spiess. In vitro binding of clathrin adaptors to sorting signals correlates with endocytosis and basolateral sorting. Embo Journal 15,2893-9 (1996)
285. H. Ohno, I Stewart, M. C Foumier, H. Bosshart, I. Rhee, S. Miyatake,T. Saito, A. Gallusser.T. Kirchhausen, and J. S. Bonifacino. Interaction of tyrosine-based sorting signals with clathrin-associated proteins. Science 269,1872-5 (1995)
286. H. Ohno, M. C Fournier, G. Poy, and J. S. Bonifacino. Structural determinants of interaction of tyrosine-based sorting signals with the adaptor medium chains. J. Biol. Chem. 271,29009-15 (1996)
287. K. A. Beck, M. Chang, F. M. Brodsky, and J. H. Keen. Clathrin assembly protein AP-2 induces aggregation of membrane vesicles: a possible role for AP-2 in endosome formation. J. Cell Biol. 119,787-96 (1992)
288. M. P. Chang,W. G. Mallet, and F. M. Brodsky. Adaptor self-aggregation, adaptor-receptor recognition and binding of a-adaptin subunits to the plasma membrane contribute to recruitment of adaptor (AP2) components of clathrin-coated pits. EMBO J. 12,2169-80 (1993)
289. M. S. Moore, D.T. Mahaffey, F. M. Brodsky, and R, G.W Anderson. Assembly of clathrin-coated pits onto purified plasma membranes. Science 236,558-63 (1987)
290. S. Ahle and E Ungewickell. Identification of a clathrin binding subunit in the H A2 adaptor protein complex. J. Biol. Chem. 264,20089-93 (1989)
291. D. T. MahafTey, J. S. Peeler, F. M. Brodsky, and R. G. W Anderson. Clathrincoated pits contain an integral membrane protein that binds the AP-2 subunit with high affinity. J. Biol. Chem. 265,16514-20 (1990)
292. U M. Pley, B. L. Hill, C Alibert, F. M. Brodsky, and P. Parham.The interaction of calmodulin with clathrin-coated vesicles, triskelions, and light chains. Localization of a binding site. J. Biol. Chem. 270,2395-402 (1995)
293. M. Forgac, L. Cantley, B. Wiedenmann, L. Altstiel, and D. Branton. Clathrincoated vesicles contain an ATP-depcndent proton pump. Proc. Natl. Acad. Sci. USA 80,1300-3 (1983)
294. D M. Schlossman, S. L. Schmid.W A. Braell, and IE Rothman. An enzyme that removes clathrin coats: Purification of an uncoating ATPase. I Cell. Biol. 99,72333(9088)0984)
295. M.-Y. Tsai and C Wang. Uncoupling of Peptide-stimulated ATPase and Clathrin-uncoating Activity in Deletion Mutant of hsc70. J. Biol. Chem. 269,595862(1994)
296. K. Prasad, I Heuser, E Eisenberg, and L. Greene. Complex Formation between Clathrin and Uncoating ATPase. J. Biol. Chem. 269,6931-9 (1994)
297. K. A. Lund, L. K. Opresko, C Starbuck, B. I Walsh, and H. S.Wiiey. Quantita-tive analysis of the endocytic system involved in hormone-induced receptor internalization. J. Biol. Chem. 265,15713-23 (1990)
298. C P. Chang, C S. Lazar, B. JLWalsh, M. Komuro, J. F. Collawn, L. A. Kuhn, J. A. Tainer, I. S. Trowbridge, M. G. Farquhar, and M. G. Rosenfeld. Ligand-induced intemalization of the epidermal growth factor receptor is mediated by multiple endocytic codes analogous to the tyrosine motif found in constitutively internalized receptors. J. Biol. Chem. 268,19312-20 (1993) -
299. S. M. Dintzis and S. R. Pfeffer.The mannose 6-phosphate receptor cytoplasmic domain is not sufficient to alter the cellular distribution of a chimeric EGF receptor. EMBO. J. 9,77-84 (1990)
300. J. M. Backer, S. E Shoelson, E Haring, and M. F. White. Insulin receptors internalize by a rapid, saturable pathway requiring receptor autophosphorylation and an intact juxtamembrane region. J. Cell. Biol. 115,1535-45 (1991)
301. J. M. Backer, S. E Shoelson, M. A.Weiss, Q. X. Hua, R. B. Cheatham, E Haring, D. C Cahill, and M. F. White. The insulin receptor juxtamembrane region contains two independent tyrosine/beta-tum intemalization signals. J. Cell Biol. 118,831-9 (1992)
302. M. Rajagopalan, l L. Neidigh, and D. A. McCIain. Amino acid sequences GlyPro-Leu-Tyr and Asn-Pro-Glu-Tyr in the submembranous domain of the insulin receptor are required for normal endocytosis. J. Biol. Chem. 266,23068-73 (1991)
303. M. Rajagopalan, L. Hebert, and D. A. McCIain. Chimeric receptors expressing juxtamembrane sequences of the insulin receptor undergo rapid endocytosis in the absence of receptor tyrosine kinase activity. Biochem. Biophys. Res. Commua 211,714-8 (1995)
304. P. Berhanu, R. H. Ibrahim-Schneck, C Anderson, and W M.Wood.The NPEY sequence is not necessary for endocytosis and processing of insulin-receptor complexes. Mol EndocrinoL 5,1827-35 (1991)
305. P. Berhanu, C Anderson, D. R. Paynter, and W M. Wood. The amino acid sequence GPLY is not necessary for normal endocytosis of the human insulin receptor B isoform. Biochem. Biophys. Res. Commun. 209,730-8 (1995)
306. E Goncalves, K.Yamada, H. S. Thatte, J. M. Backer, D. E Golan, C R. Kahn, and S. E Shoelson. Optimizing transmembrane domain helicity accelerates insulin receptor internalization and lateral mobility. Proc. Natl. Acad. Sci. USA 90,5762-6(1993)
307. S. C. Li, G M. Deber, and S. E Shoelson. An irregularity in the transmembrane domain helix correlates with the rate of insulin receptor intemalization. Biochemistry. 33,14333-8 (1994)
308. W J. Chen, J. L. Goldstein, and M. S. Brown. NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated intemalization of the low density lipoprotein receptor. J. Biol. Chem. 265,3116-23 (1990)
309. S. Mon, L. Claesson-Welsh, and C H. Heldin. Identification of a hydrophobic region in the carboxyl terminus of the platelet-derived growth factor beta-receptor which is important for ligand-mediated endocytosis. J. Biol. Chem. 266,21158-64(1991)
310. S. Mori, L Ronnstrand, L. Claesson Welsh, and C H. Heldin. A tyrosine residue in the juxtamembrane segment of the platelet-derived growth factor beta-receptor is critical for ligand-mediated endocytosis. J. Biol. Chem. 269,4917-21 (1994)
311. D. Hsu, P. E Knudson, A. Zapf, G. C Rolband, and J. M. Olefsky. NPXYmotif in the insulin-like growth factor-I receptor is required for efficient ligandmediated receptor internalization and biological signaling. Endocrinology 134,744-50(1994)
312. D. Prager, H. L. Li, H.Yamasaki, and S. Melmed. Human insulin-like growth factor I receptor intemalization. Role of the juxtamembrane domain. J. Biol. Chem. 269,11934-7 (1994)
313. J. F. Collawn, A. Lai, D. Domingo, M. Fitch, S. Hatton, and I. S. Trowbridge. YTRF is the conserved internalization signal of the transferrin receptor, and a second YTRF signal at position 31-34 enhances endocytosis. J. Biol. Chem. 268,21686-92(1993)
314. M. Jadot.W M. Canfield.W. Gregory, and S. Kornfeld. Characterization of the signal for rapid internalization of the bovine mannose 6-phosphate/insulin-like growth factor-II receptor. J. Biol. Chem. 267,11069-77 (1992)
315. K. F. Johnson and S. Kornfeld. The cytoplasmic tail of the mannose 6-phosphate/insulin-like growth factor-II receptor has two signals for lysosomal enzyme sorting in the Golgi. J. Cell. Biol. 119,249-57 (1992)
316. R. C Kurten, D. L. Cadena, and G. N. Gill. Enhanced degradation of EGF receptors by a sorting nexin, SNX1. Science. 272,1008-10 (1996)
317. J. Herbst, L. K. Opresko, B. IWalsh, D. A. Lauffenburger, and H. S.Wiley. Regulation of postendocytic trafficking of the epidermal growth factor receptor through endosomal retention. Jl Biol. Chem. 269,12865-73 (1994)
318. A. Bansal and L. M. Gierasch.The NPXY intemalization signal of the LDL receptor adopts a reverse-turn conformation. Cell 67,1195-201 (1991)
319. R.Y. Wu and G. N. Gill. LIM domain recognition of a tyrosine-containing tight turn. 3. Biol. Chem. 269,25085-90 (1994)
320. R. Wu, K. Durick, Z. Songyang, L. C Cantley, S. S Taylor, and G N. GilL Specificity of LIM domain interactions with receptor tyrosine kinases. J. Biol. Chem. 271,15934-41(1996)
321. K. Durick, R. Y. Wu, G. N. Gill, and S. S. Taylor. Mitogenic signaling by Ret/ ptc2 requires association with enigma via a LIM domain. J. BioL Chem. 271,12691-4(1996)
322. O. B. Goodman.Jr., J. G. Krupnick, F. Sanuni.V.V. Gurevich, R. B. Penn, A.W. Gagnon, i H. Keen, and J. L. Benovic. beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. Nature 383,447-50 (1996)
323. S. H. Lillie and S. S. Brown. Suppression of a myosin defect by a kinesin-related gene. Nature 356,358-61 (1992)
324. R. A. Obar, H. S. Shpetner, and R. B.Vallee. Dynamin: A Microtubule-associated GTP-binding Protein. J. Cell. Sci. 14,143-5 (1991)
325. J. L. CJT and S. T. Brady. Molecular Motors in Axonal Transport. Cellular and Molecular Biology of Kinesin. Mol Neurobiol. 6,137-55 (1992)
326. Maeda.K.,T. Nakata, Y Noda, R. Sato-Yoshitake, and N. Hirokawa. Interaction of Dynamin with Microtubules: Its Structure and GTPase Activity Investigated by Using Highly Purified Dynamin. MoL Biol. Cell 3,1181-94 (1992)
327. K. Ekena, C AA'ater, C K. Raymond, and T. H. Stevens.The VPS1 protein is a dynamin-like GTPase required for sorting proteins to the yeast vacuole. Ciba Found. Symp. 176,198-214 (1993)
328. K.Wilsbach and G. S. Payne.Vpslp, a member of the dynamin GTPase famil, is necessary for Golgi membrane protein retention in Saccharomyces cerevisiae. EMBOJ. 12,3049-59 (1993)
329. C AA'ater, C K. Raymond, K. Ekena, I. Howald-Stevenson, and T. H. Stevens. The VPS1 Protein, a Homolog of Dynamin Required for Vacuolar Protein Sorting in Saccharomyces cerevisiae, is a GTPase withTwo Functionally Seperable Domains. J. Cell. Biol. 119,773-86 (1992)
330. E Yeh, R. Driscoll, M. Coltrera, A. Olins, and K. Bloom. A dynamin-like protein encoded by the yeast sporulation gene SPO15. Nature 349,713-5 (1991)
331. M. Sontag, E M. Fykse,Y. Ushkaryov, I P. Liu, P. J. Robinson, and T. C Sudhof. Differential expression and regulation of multiple dynamins. J. Biol. Chem. 269,4547-54(1994)
332. T. Z. Petrovich, I Merakowsky, and L. E Kelly. A genetic analysis of the stoned locus and its interaction with dunce, shibire, and Supressor of stoned variants of Drosophila melanogaster. Genetics 133,955-65 (1993)
333. M. S. Chen, C C Burgess, R. B.Vallee, and S. CWadsworth. Developmental Stage- and Tissue-specific Expression of shibire, a Drosophila Gene Involved in Endocytosis. J. Cell. Sci. 103,619-28 (1992)
334. M. S. Chen, R. A. Obar, C C Schroeder.T.W. Austin, C A. Poodry, S. C Wadsworth, and R. B. Vallee. Multiple forms of dynamin are encoded by shibire, a Drosophila gene involved in endocytosis. Nature 351,583-6 (1991)
335. A. M. van der Bliek and E M. Meyerowitz. Dynamin-like protein encoded by the Drosophila shibire gene associated with vesicular traffic. Nature 351,411-4 (1991)
336. T. A. Cook, R. Urrutia, and M. A. McNiven. Identification of dynamin 2, an isoform ubiquitously expressed in rat tissues. Proc. Natl. Acad. Sci. USA 91, 644-8(1994)
337. T. Nakata, R.Takemura, and N. Hirokawa. A Novel Member of the Dynamin Family of GTP-binding Proteins Is Expressed Specifically in theTestis. J. Cell Sci. 105,1-5 (1993)
338. J. S. Herskovits, H. S. Shpetner, C C Burgess, and R. B.Vallee. Microtubules and Src homology 3 domains stimulate dynamin GTPase via its C-terminal domain. Proc. Natl. Acad. Sci. USA 90,11468-72 (1993)
339. H. S. Shpetner and R. B. Vallee. Dynamin Is a GTPase Stimulated to High Levels of Activity by Microtubules. Nature 355,733-5 (1992)
340. A. S. Andersen. Reception and Transmission. Nature 337,12 (1989)
341. T. Nakata, R. Sato-Yoshitake, Y. Okada.Y. Noda, and N. Hirokawa. Thermal drift is enough to drive a single microtubule along its axis even in the absence of motor proteins. Biophys. J. 65,2504-10 (1993)
342. G. S. Bloom, B. W Richards, P. L Leopold, D. M. Ritchey, and S. T. Brady. GTP gamma S Inhibits OrganelleTransport Along Axonal Microtubules. J. Cell Biol. 120,467-76(1993)
343. L, H.Wang.T. C Sudhof, and R. G. Anderson. The appendage domain of alpha-adaptin is a high-affinity binding site for dynamin. J. Biol. Chem. 270,10079-83 (1995)
344. P. J. Robinson, J. M. Sontag, J. P. Liu, E. M. Fykse, C Slaughter, H. McMahon, and T. C Sudhof. Dynamin GTPase regulated by protein kinase C
345. Robinson.RJThe role of protein kinase C and its neuronal substrates dephosphin, B-50, and Marcks in neurotransmitter release, Mol. NeurobioL 5,87-130 (1991)
346. P. LTuma, M. C Stachniak, and C A. Collins. Activation of Dynamin GTPase by Acidic Phospholipids and Endogenous Rat Brain Vesicles. J. Biol. Chem. 268,17240-6(1993)
347. A. M. van der Bliek,T. E Redelmeier, H. Damke, E ITisdale, E M. Meyerowitz, and S. L. Schmid. Mutations in human dynamin block an intermediate stage in coated vesicle formation. J. Cell Biol. 122,553-63 (1993)
348. Z-Wang and M. F. Moran. Requirement for the adapter protein GRB2 in EGF receptor endocytosis. Science 272,1935-9 (1996)
349. J. E Hinshaw and S. L. Schmid. Dynamin self-assembles into rings suggesting a mechanism for coated vesicle budding. Nature 374,190-2 (1995)
350. K.Takel, P. S. McPherson, S. L. Schmid, and P. De Camilli. Tubular membrane invaginations coated by dynamin rings are induced by GTP-gamma S in nerve terminals. Nature 374,186-90 (1995)
351. Shupliakov, P. Low, D. Grabs, H. Gad, H. Chen, C David, K.Takei, P. De Camilli, and L. Brodin. Synaptic vesicle endocytosis impaired by disruption of dynamin-SH3 domain interactions. Science 276,259-63 (1997)
352. M. JWalsh and N. Kuruc.The postsynaptic density: constituent and associated proteins characterized by electrophoresis, immunoblotting, and peptide sequencing. J. Neurochem. 59,667-78 (1992)
353. K. G. Rothberg, J. E Heuser.W C Donzell,Y.-S.Ying, J. R. Glenney, and R. G. W. Anderson. Cavcolin, a Protein Component of Caveolae Membrane Coats. Cell 68,673-82 (1992)
354. J. R. Glenney and D. Soppet. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyro-sine in Rous sarcoma virus-transformed fibroblasts. Proc. Nail. Acad Sci. USA 89,10517-21 (1992)
355. P. E Bickel, P. E Scherer, J. E Schnitzer, P. Oh, M. P. Lisanti, and H. F. Lodish. Flotillin and epidermal surface antigen define a new family of caveolae-associated integral membrane proteins. J. Biol. Chem. 272,13793-802 (1997)
356. P. E Scherer,T. Okamoto, M. Chun, I. Nishimoto, H. F. Lodish, and M. P. Lisanti. Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc. Natl. Acad. Sci. USA 93,131-5 (1996)
357. R. L Goldberg, R. M. Smith, and L. Jarett. Insulin and alpha 2-macroglobulinmethylamine undergo endocytosis by different mechanisms in rat adipocytes: I. Comparison of cell surface events. J. Cell. Physiol. 133,203-12 (1987)
358. R. I. Goldberg, R. M. Smith, and L. Jarett. Insulin and alpha 2-macroglobulinmethylamine undergo endocytosis by different mechanisms in rat adipocytes: II. Comparison of intracellular events. J. Cell. Physiol. 133,213-8 (1987)
359. P. E Scherer, M. P. Lisanti, G. Baldini, M. Sargiacomo, C C Mastick, and H. F. Lodish. Induction of Caveolin during Adipogenesis and Association of GLUT4 with Caveolin-rich Vesicles. J. Cell Biol. 127,1233-43 (1994)
360. R. G.W. Andersen, R A. Kamen, K. G. Rothberg, and S.W Lacey. Potocytosis: Sequestration and Transport of Small Molecules by Caveolae. Science 255,4101 (1992)
361. JTravis. Cell Biologists Explore Tiny Caves. Science 262,1208-9 (1993)
362. R. G.W Anderson. Caveolae: Where incoming and outgoung messengers meet. Proc. Natl. Acad. Sci. USA 90,10909-13 (1993)
363. T. Fujimoto, S. Nafcade, A. Miyawaki, K. Mikoshiba, and K. Ogawa. Localization of Inositol 1,4,5-Trisphosphate Receptor-like Protein in Plasmalemmal Caveolae. J. Cell Biol. 119,1507-13 (1992)
364. T. Fujimoto. Calcium Pump of the Plasma Membrane is Localized in Caveolae. J. Cell BioL 120,1147-57 (1993)
365. T. Fujimoto, A. Miyawaki, and K. Mikoshiba. Inositol 1,4,5-trisphosphate receptor-like protein in plasmalemmal caveolas is linked to actin filaments. J. Cell Sci. 108,7-15 (1995)
366. M. Sargiacomo, M. SudoIJang, and M. P. Lisanti. Signal Transducing Molecules and Glycosyl-phosphatidylinositol-linked Proteins Form a caveolin-rich Insoluble Complex in MDCK Cells. J. Cell Biol. 122,780-807 (1993)
367. M. P. Lisanti, P. E Scherer, JVidugiriene, Z.Tang, A. Hermanowski-Vosatka,Y.H. Tu, R. F. Cook, and M. Sargiacomo. Characterization of Caveolin-rich Membrane Domains Isolated from an Endothelial-rich Source: Implications for Human Disease. J. Cell Biol. 126,111-26 (1994)
368. W-J. Chang.Y.Ying, K. G Rothberg, N. M. Hooper, A. J. Turner, H. A. Gambliel, J. D. Gunzburg, S. M. mumby, A. G. Oilman, and R. G.W. Anderson. Purification and Characterization of Smooth Muscle Caveolae. J. Cell Biol. 126,127-38(1994)
369. M. Chun, U K. Liyabage, M. P. Lisanti, and H. F. Lodish. Signal transductionof a G protein-coupled receptor in caveolae: Colocalization ofendothelin and its receptor with caveolin. Proc. Natl. Acad. Sci. USA 91,11728-32 (1994)
370. S. Mayor, K. G. Rothberg, and F. R. Maxfield Sequestration of GPI-Anchored Proteins in CaveolaeTriggered by Cross-Linking. Science 264,1948-51 (1994)
371. E J. Smart, D. C Foster,Y.-S. Ying, B. A. Kamen, and R. G. W Anderson. Protein Kinase C Activators Inhibit Receptor-Mediated Potocytosis by Preventing Internalization of Caveolae. J. Cell Biol. 124,307-13 (1994)
372. E l Smart,Y.-S. Ying, P. A. Conrad, and R. G. W Anderson. Caveolin Moves from Caveolae to the Golgi Apparatus in Response to Cholesterol Oxidation. J. Cell Biol. 127,1185-97 (1994)
373. R. G. Parton, B. Joggerst, and K. Simons. Regulated Internalization of Caveolae. J. Cell Biol. 127,1199-215 (1994)
374. J. R. Glenney, Jr.The sequence of human caveolin reveals identity with VIP21, a component of transport vesicles. FEBS Lett. 314,45-8 (1992)
375. TV. Kurzchalia, P. Dupree, R. G. Parton, R. Kellner, H.Virta, M. Lehnert, and K. Simons. VIP21, a 21-kD membrane protein is an integral component of trans-Golgi-network-derived transport vesicles. J. Cell. Biol. 118,1003-14 (1992)
376. E. Schnitzer, P. Oh, and D. P. Mclntosh. Role of GTP hydrolysis in fission of caveolae directly from plasma membranes. Science 274,239-42 (1996)
377. S. L. Shyng, M. T. Huber, and D. A. Harris. A prion protein cyles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. Proc. Natl. Acad Sci. USA 268,15922-8 (1993)
378. S. L. Shyng, J. E Heuser, and D. A. Harris. A glycolipid-anchored prion protein is endocytosed via clathrin-coated pits. J. Cell Biol. 125,1239-50 (1994)
379. P. J. Green, M. A. J. Ferguson, P. J. Robinson, and T. FeizLThe cation-independent mannose-6-phosphate receptor binds to soluble GPI-linked proteins via mannose-6-phosphate. FEBS Lett. 360,34-8 (1995)
380. i Chakrabarti, J. Buxton, M. Joly, and S. Corvera. Insulin-sensitive Association of GLUT-4 with Endocytic Clathrin-coated Vesicles Revealed with the Use of Brefeldin A. J. Biol. Chem. 269,7926-33 (1994)
381. L. J. Robinson, S. Pang, D. S. Harris, J. Heuser, and D. E James. Translocation of the glucose transporter (GLUT4) to the cell surface in permeabilized 3T3-L1 adipocytes: effects of ATP insulin, and GTP gamma S and localization of GLUT4 to clathrin lattices. J. Cell. Biol. 117,1181-96 (1992)
382. P. E Scherer, M. P. Lisanti, G. Baldini, M. Sargiacomo, C C Mastick, and H. F. Lodish. Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles. J. Cell. Biol. 127,1233-43 (1994)
383. M.Voldstedlund, J. Tranum-Jensen, and J.Vinten. Quantitaten of Na+/K+-ATPase and GlucoseTransporter Isoforms in Rat Adipocyte Plasma Membrane by Immunogold Labeling. J. Membrane Biol. 136,63-73 (1993)
384. P. E Pilch, M. A. Shia, R. I Benson, and R. E Fine. Coated vesicles participate in the receptor-mediated endocytosis of insulin. I Cell. Biol. 96,133-8 (1983)
385. J. P. Paccaud, K. Siddle, and J L. Carpentier. Internalization of the human insulin receptor.The insulin-independent pathway. J. Biol. Chem. 267,13IOI-6 (1992)
386. J. P. Paccaud.W Reith, B. Johansson, K. E Magnusson, B. Mach, and J. L. Carpentier. Clathrin-coated pit-mediated receptor internalization. Role of internalization signals and receptor mobility. J. Biol. Chem. 268,23191-6 (1993)
387. C C Mastick, M. J. Brady, and A. R. SaltieL Insulin stimulates the tyrosine phosphorylation of caveolin. I Cell Biol. 129,1523-31 (1995)
388. J. L. Carpentier, J. P. Paccaud, P. Gorden,W I Rutter, and L. Orci. Insulin-induced surface redistribution regulates internalization of the insulin receptor and requires its autophosphorylatioa Proc. Natl. Acad. Sci. USA 89,162-6 (1992)
389. L. A. Hannan, M. P. Lisanti, E Rodriguez Boulan, and M. Edidin. Correctly sorted molecules of a GPI-anchored protein are clustered and immobile when they arrive at the apical surface of MDCK cells. J. Cell Biol. 120,353-8 (1993)
390. E Yechiel and M. Edidin. Micrometer-scale domains in fibroblast plasma membranes. J. Cell Biol. 105,755-60 (1987)
391. M. Edidin and I. Stroynowski. Differences between the lateral organization of conventional and inositol phospholipid-anchored membrane proteins. A farther definition of micrometer scale membrane domains. J. Cell Biol. 112,1143-50(1991)
392. M. Edidin, S. C Kuo, and M. P. Sheetz, Lateral movements of membrane glycoproteins restricted by dynamic cytoplasmic barriers. Science 254,1379-82 (1991)
393. K. Simons and E. Ikonen. Functional rafts in cell membranes. Nature 387,56972(1997)
394. M. Yang, I Ellcnberg, J. S. Bonifacino, and A. M. Weissman. The transmembrane domain of a carboxyl-terminal anchored protein determines localization to the endoplasmic reticulum. J. Biol. Chem. 272,1970-5 (1997)
395. K. L. Constantine, C Mapelli, C A. Meyers, M. S. Friedrichs, S. Krystek, and L. Mueller. Micelle-bound conformational preferences of a peptide derived from a murine major histocompatibility complex class I molecule. J. Biol. Chem. 268,22830-7 (1993)
396. W. F. DeGrado, Z. R.Wasserman, and J. D. Lear. Protein Design, A Minimalist Approach. Science 243,622-8 (1989)
397. B.W. Matthews, C S. Craik, and H. Neurath. Can small cyclic peptides have the activity and specificity of proteolytic enzymes? Proc, Natl. Acad. Sci. USA 91,4103-5(1994)
398. http://www.cryst.bbk.ac.uk/PPS/course/9iiuaternary/insulin.html.
399. T. L. Blundell, J. F. Cutfield, S. M. Cutfield, E I Dodson, G. G. Dodson, D. C Hodgkin, D. A. Mercola, and M.Vijayan. Atomic positions in rhombohedral 2zinc insulin crystals. Nature 231,506-11 (1971)
400. Q. X. Hua, S. E Shoelson, M. Kochoyan, and M. AAVeiss. Receptor binding redefined by a structural switch in a mutant human insulin. Nature 354,238-41 (1991)
401. Q. X. Hua, S. N. Gozani, R. E Chance, J. A. Hoflmann, B. H. Frank, and M. A. Weiss. Structure of a protein in a kinetic trap. Nat. Struct. Biol. 2,129-38 (1995)
402. K. Sasaki, S. Dockerill, D. A. Adamiak, I. J. Tickle, and T. Blundell. X-ray analysis of glucagon and its relationship to receptor binding. Nature 257,751-7 (1975)
403. U Derewenda, Z. Derewenda, E J. Dodson, G. G. Dodson, X. Bing, and J. Markussen. X-ray analysis of the single chain B29-A1 peptide-linked insulin molecule. A completely inactive analogue. J. Mol Biol. 220,425-33 (1991)
404. R. L, Baldwin. Alpha-helix formation by peptides of defined sequence. Biophys. Chem. 55,127-35 (1995)
405. J. M. Scholtz, D. Barrick, E J. York, J. M. Stewart, and R. L. Baldwin. Urea unfolding of peptide helices as a model for interpreting protein unfolding. Proc. Natl. Acad. Sci. USA 92,185-9 (1995)
406. A. Chakrabartty.T. Kortemme, and R. L. Baldwin. Helix propensities of the amino acids measured in alanine-based peptides without helix-stabilizing side-chain interactions. Protein. Sci. 3,843-52 (1994)
407. Y. Shai. Molecular recognition between membrane-spanning polypeptides. Trends. Biochem. Sci. 20,460-4 (1995)
408. K. R. MacKenzie, I H. Prestegard, and D. M. Engelman. A transmembrane helix dimer: structure and implications. Science 276,131-3 (1997)
409. P. C Driscoll, J. D. Altaian, J. I Boniface, K. Sakaguchi, P. A. Reay, J. G. Omichinski, E Appella, and M. M. Davis. Two-dimensional nuclear magnetic resonance analysis of a labeled peptide bound to a class II major histocompatibility complex molecule. J. Mol. Biol. 232,342-50 (1993)
410. J. Trowsdale. Genomic structure and function in the MHC Trends. Genet. 9,117-22(1993)
411. H.Wei.W.-F. Fan, H. Xu, S. Parimoo, H. Shukla, D. D. Chaplin, and S. M. Weissman. Genes in one megabase of the HLA class I region. Proc. Natl. Acad. Sci. USA 90,11870-4 (1993)
412. J. Trowsdale and R. D. Campbell. Complexity in the major histocompatibility complex. Eur. J. Immunogen. 19,45-55 (1992)
413. 4I3CVernet, M.T. Ribouchon, G. Chimini, A. M. Jouanolle, I. SidibS, and P. Pontarotti. A novel coding sequence belonging to a new multicopy gene family mapping within the human MHC class I region. Immunogenetics 38,47-53 (1993)
414. M. Janatipour,V. Naumov, A. Ando, K. Sugimura, N. Okamoto, K.Tsuji, K. Abe, and H. Jnoko. Search for MHC-associated genes in human: five new genes centromeric to HLA-DP with yet unknown functions. Immunogenetics 35,2728 (1992)
415. A. Kelly, S. H. Powis, L. A. Kerr, I. Mockridge,T. Elliott, J. Bastin, R Uchanska-Ziegler, A. Ziegler, J. Trowsdale, and A. Townsend. Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex. Nature 355,641-4 (1992)
416. M. G. Brown, J. Driscoll, and I I Monaco. MHC-linked low-molecular mass polypeptide subunits define distinct subsets of proteasomes. Implications for divergent function among distinct proteasome subsets. J. Immunol. 151,1193204(1993)
417. M. J. Kleijmeer, A. Kelly, H. J. Geuze, J.W Slot, A.Townsend, and JTrowsdale. Location of MHC-encoded transporters in the endoplasmic reticulum and cisGolgi. Nature 357,342-4 (1992)
418. S I Powis, EV. Deverson,W I Coadwell, A. Cirela, N. S. Huskisson, H. Smith, G W Butcher, and J. C Howard. Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule. Nature 357,211-5 (1992)
419. S. M. Hedrick. Dawn of the hunt for nonclassical MHC function. Cell 70,177-80 (1992)
420. S. C Spencer and J.W. Fabre. Identification in rat liver and serum of water-soluble class I MHC molecules possibly homologous to the murine Q10 gene product. 1 Exp. Med. 165,1595-608 (1987)
421. P. Tabaczewski, H. Shirwan, K. Lewis, and I. Stroynowski. Alternative splicing of class Ib major histocompatibility complex transcripts in vivo leads to the expression of soluble Qa-2 molecules in murine blood. Proc. Natl. Acad. Sci. USA 91,1883-7(1994)
422. K. Wonigeit and L. Hanish. Two new class I loci in the rat major histocompatibility complex: RT1.L and RT1.M. Transplant. Proc, 23,468-70 (1991)
423. S. C Jameson,W D.Tope, E M.Tredgett, J. M.Windle, A. G. Diamnd, and J. C Howard. Cloning and expression of class I major histocompatibility complex genes of the rat. 1 Exp. Med 175,1749-57 (1992)
424. C Rada, R. Lorenzi, S. J. Powis, J.V. D. Bogaerde, P. Parham.and, and J.C Howard. Concerted evolution of class I genes in the major histocompatibility complex of murine rodents. Proc, Natl. Acad Sci. USA 87,2167-71 (1990)
425. K. E. Parker, C A. Carter, G. Murphy, and J.W. Fabre.The rat RT.BM1 MHC class I cDNA shows a high level of sequence similarity to the mouse H-2T23d gene. Immunogenetics 34,211-3 (1991)
426. P. I Bjorkman, M. A. Saper, R Samaraoui,W. S. Bennett, J. L. Strominger, and D. CWiley. Structure of the Human Class I Histocompatibility Antigen, HLAA2. Nature 329,506-12 (1987)
427. T. P. J. Garret, M. A. Saper, P. J. Bjorkman, J. L. Strominger, and D. CWiley. Specificity Pockets for the Side Chains of Peptide Antigens in HLA-Aw68. Nature 342,692-6 (1989)
428. M. A. Saper, P. J. Bjorkman, and D. CWiley_. Refined Structure of the Human Histocompatibility Antigen HLA-A2 at 2.6 A Resolution. J. MoL Biol. 219,277319(1991)
429. D. R. Madden, J. C Gorga, J. L. Strominger, and D. CWiley. The Three-Dimensional Structure of HLA-B27 at 2.1 A Resolution Suggests a General Mechanism for Tight Peptide Binding to MHC Cell 70,1035-48 (1992)
430. W Zhang, A. C M. Young, M. Imarai, S. G. Nathenson, and I C. Sacchettini. Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: Implications for peptide binding and Tcell receptor recognition. Proc. Natl. Acad Sci. USA 89,8403-7 (1992)
431. D. H. Fremont, M. Matsumura, E. A. Stura, P. A. Peterson, and I. A. Wilson. Crystal Structures of Two Viral Peptides in Complex with Murine MHC Class I H-2Kb. Science 257,919-27 (1992)
432. A. C M. Young, W. Zhang, J. C Sacchettini, and S. G. Nathenson. The ThreeDimensional Structure of H-2Db at 2.4 A Resolution: Implications for Antigen-Determinant Selection. Cell 6,39-50 (1994)
433. S. S. Hall. Protein Images Update Natural History. Science 267,620^ (1995)
434. J. H. Brown,T. S. Jardetzky, J. C Gorga, L. J. Stern, R. G. Urban, J. L. Strominger, and D. CWiley. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature. 364,33-9 (1993)
435. L. I Stern, J. H. Brown,T. S. Jardetzky, J. C Gorga, R. G. Urban, J. L, Strominger, and D. CWiley. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature. 368,215-21 (1994)
436. P. J. Bjorkman, M. A. Saper, B. Samaraoui,W S. Bennett, I L. Strominger, and D. CWiley. The Foreign Antigen Binding Site and T-cell Recognition Regions of Class I Histocompatibility Antigens. Nature 329,512-8 (1987)
437. M. Matsumura, D H. Fremont, P. A. Peterson, and I. AAVilsoa Emerging Principles for the Receognition of Peptide Antigens by MHC Class I Molecules. Science 257,927-34(1992)
438. D. R. Madden, J. C Gorga, J. L Strominger, and D. C Wiley. The Structure of HLA-B27 Reveals Nonamer Peptides Bound in an Extended Conformation. Nature 353,321-5 (1991)
439. G. M.Van Bleek and S. G. Nathenson. The structure of the antigen-binding groove of major histocompatibility complex class I molecules determines specific selection of self-peptides. Proc. Natl. Acad Sci. USA 88,11032-6 (1991)
440. M. Corr, L. F. Boyd, S. R. Frankel, S. Kozlowski, E A. Padlan, and D. H. Margulies. Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2L : sequence motif, quantitative binding, and molecular modeling of the complex. J. Exp. Med. 176,1681-92 (1992)
441. K. Falk, O. Rotzchke, and H.-G. Rammensee. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351,290-6 (1992)
442. D. F. Hunt, R. A. Henderson, J. Shabanowitz, K. Sakaguchi, H. Michel, N. Sevilir, A. L. Cox, E Appelia, and V. H. Engelhard. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255,1261-3 (1992)
443. L. D. Barber and P. Parham. Peptide binding to major histocompatibility complex molecules. Annu. Rev. Cell Biol. 9,163-206 (1993)
444. H.-C Guo,T. S. Jardetsky.T. P. J. Garrett.W. S. Lane, J. L. Strominger, and D. C Wiley. Different length polypeptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle. Nature 360,364-6 (1992)
445. R. G. Urban, R. M. Chicz,W. S. Lane, J. L. Strominger, A. Rehm, M. J. H. Kenter, F. G. C M. UytdeHaag, H. Ploegh, R Uchanska-Ziegler, and A. Ziegler. A subset of HLA-B27 molecules contains peptides much longer than nonamers. Proc. Nail. Acad. Sci. USA 91,1534-8 (1994)
446. S. Joyce, K. Kuzushima, G. Kepecs, R. H. Angeletti, and S. G. Nathensoa Characterization of an incompletely assembled major histocompatibility class I molecule (H-2Kb) associated with unusually long peptides: implications for antigen processing and presentatioa Proc. Natl. Acad Sci. USA 91,4145-9 (1994)
447. M. Matsumura,Y. Saito, M. R. Jackson, E. S. Song, and P. A. Peterson. In vitro peptide binding to soluble empty class I major histocompatibility complex molecules isolated from transfected Drosophila melanogaster cells. J. Biol. Chem. 267,23589-95(1992)
448. D. R. Madden, D. N. Garboczi, and D. CWiley.The antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75,693-708 (1993)
449. L A. Sherman, S. Chattopadhyay, J. A. Biggs, R. F. Dick II, and J. A. Bluestone. Alloantibodies can discriminate class I major histocompatibility complex molecules associated with various endogenous peptides. Proc. Natl. Acad. Sci. USA 90,6949-51 (1993)
450. E J. Collins, D. N. Garboczi, M. N. Karpusas, and D. CWiley.The three-dimensional structure of a class I major histocompatibility complex molecule missing the alpha 3 domain of the heavy chain. Proc, Natl. Acad. Sci. USA 92,1218-21(1995)
451. K. G Garcia, M. Degano, R. L Stanfield, A. Brunmark, M. R. Jackson, P. A. Peterson, LTeyton, and I. A. Wilsoa An abT Cell Receptor Structure at 2.5 A and Its Orientation in theTCR-MHC Complex. Science 274,209-19 (1996)
452. D. N. Garboczi, P. Ghosh, U Utz, Q. R. Fan,W E Biddison, and D. C Wiley. Structure of the complex between human T-cell receptor, viral peptide and HLA-A1 Nature 384,134-41 (1996)
453. J. P. Abastado,Y. C Lone, A. Casrouge, G. Boulot, and P. Kourilsky. Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness. J. Exp.Med. 182,439-47 (1995)
454. P. J. Bjorkman. MHC restriction in three dimensions: a view of T cell receptor/ ligand interactions. Cell 89,167-170 (1997)
455. Y. Yamane, M. Ferez, R. Edelson, N. Agostino, and R Pernis. Endocytosis of the TCR/CD3 complex and the class-I major histocompatibility complex in a humanTcell line. Cell Immunol. 136,496-503 (1991)
456. F. Luton, M. Buferne, J. Davoust, A. M. Schmitt Verhulst, and C Boyer. Evidence for protein tyrosine kinase involvement in ligand-induced TCR/CD3 intemalization and surface redistribution. J. Immunol. 153,63-72 (1994)
457. J. Dietrich, X. Hou, A. M. Wegener, and C Geisler. CD3 gamma contains a phosphoserine-dependent di-leucine motif involved in down-regulation of the T cell receptor. EMBO J. 13,2156-66 (1994)
458. T. Tscherning and M. H. Claessoa Signal transduction via MHC class-I molecules inTcells. Scand. J. Immunol.39,117-21 (1994)
459. S. Skov, N. Odum, and M. H. Claesson. MHC class I signaling inT cells leads to tyrosine kinase activity and PLC-gamma 1 phosphorylatioa J. Immunol. 154,1167-76(1995)
460. S. Bregenholt, M. Ropke, S. Skov, and M. H. Claesson. Ligation of MHC class I molecules on peripheral blood T lymphocytes induces new phenotypes and functions. J. Immunol. 157,993-9 (1996)
461. P. A. Giblin, D. J. Leahy, J. Menonne, and P. B. Kavathas. The role of charge and multiple faces of the CD8(o/a) homodimer in binding to major histocompatibility complex class I molecules: Support for a bivalent model. Proc. Natl. Acad. Sci. USA 91,1716-1720 (1994)
462. G. F. Gao, JTormo, U C Gerth, J. R.Wyer, A. J McMichael, D. I. Stuart, J. I. Bell, E Y Jones, and B. K. Jakobsea Crystal structure of the complex between human CD8alpha(alpha) and HLA- A2. Nature 387,630-4 (1997)
463. E R. Christinck, M. A. Luscher, B. H. Barber, and D. B. Williams. Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis. Nature 352,67-70 (1991)
464. R. N. Germain. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activatioa Cell 76,287-99 (1994)
465. J. S. Haurum, G. Arsequell, A. C Lellouch, S.Y.Wong, R. A. Dwek, A. J. McMichael, and T. Elliott. Recognition of carbohydrate by major histocompatibility complex class I-restricted, glycopeptide-specific cytotoxic T lymphocytes. I Exp. Med. 180,739-44 (1994)
466. J. S. Haurum, L.Tan, G Arsequell, P. Frodsham, A. C Lellouch, P. A. Moss, R. A. Dwek, A. J. McMichael, and T. Elliott. Peptide anchor residue glycosylation: effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognition. Eur J Immunol 25,3270-006 (1995)
467. P. Parham. Chewing the fat. Nature 372,615-6 (1994)
468. K. Karre. Express yourself or die: Peptides, MHC molecules, and NK cells. Science 267,978-9 (1995)
469. K. Fruh, K. Ahn, H. Djaballah, P. Sempe, P. M. van Endert, R.Tampe, P. A. Peterson, and Y.Yang. Aviral inhibitor of peptide transporters for antigen presentatioa Nature. 375,415-8 (1995)
470. X. Liu, R. Ge, S. Westmorland, A. J. Cooney, S. Y Tsai, M. J. Tsai, and R. P. Ricciardi. Negative regulation by the R2 element of the MHC class I enhancer in adenovirus-12 transformed cells correlates with high levels of COUP-TF binding. Oncogene. 9,2183-90 (1994)
471. YYamashita, K. Shimokata, S. Saga, S. Mizuno,T.Tsurumi, and Y Nishiyama. Rapid degradation of the heavy chain of class I major histocompatibility complex antigens in the endoplasmic reticulum of human cytomegalovirus-infected cells. IViroL 68,7933-43 (1994)
472. 1 & Bonifacino. Reversal of fortune for nascent proteins. Nature 384,405-6 (1996)
473. E. I. Wiertz, D.Tortorella, M. Bogyo, J.Yu,W. Mothes,T. R. Jones.T. A. Rapo-port, and H. L. Ploegh. Secol-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384,432-8(1996)
474. N. J. Davis-Poynter and H. E Farrell. Masters of deception: a review of herpesvirus immune evasion strategies. Immunol. Cell Biol.74,513-22 (1996)
475. E J. Wiertz, S. Mukherjee, and H. L. Ploegh. Viruses use stealth technology to escape from the host immune system. Mol. Med. Today 3,116-23 (1997)
476. M. S. Malnati, M. Peruzzi, K. G Parker.W E Biddison, E Ciccone, A. Moretta, and E O. Long. Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 267,1016-8 (1995)
477. O. Mandelboim, H.T. Reyburn, E G. Sheu, M.Vales-Gomez, D. M. Davis, L. Pazmany, and I L. Strominger. The binding site of NK receptors on HLA-C molecules. Immunity. 6,341-50 (1997)
478. L. Pazmany, O. Mandelboim, M.Vales-Gomez, D. M. Davis, H.T. Reyburn, and J. L. Strominger. Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 274,792-5 (1996)
479. J.V. Ravetch and D. H. Margulies. New tricks for old molecules. Nature 372,3234(1994)
480. W P. Burmeister, L. N. Gastinel, N. E Simister, M. L. Blum, and P. J. Bjorkmaa Crystal structure at 2.2 A resolution of the MHC-related neonatal Fc receptor. Nature 372,336-43 (1994)
481. W P. Burmeister, A. H. Huber, and P. J. Bjorkman. Crystal structure of the complex of rat neonatal Fc receptor with Fc. Nature 372,379-83 (1994)
482. M. Raghavan,Y. Wang, and P. I Bjorkman. Effects of receptor dimerization on the interaction between the class I major histocompatibility complex-related Fc receptor and IgG Proc. Natl. Acad. Sci. U S. A. 92,11200-4 (1995)
483. T. S. Jardetzky, J. H. Brown, J. C Gorga, L l Stern, R. G. Urban.Y. I. Chi, C Stauffacher, J. L. Strominger, and D. GWiley. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature. 368,711-8 (1994)
484. P. Parham. A profitable lesson in heresy. Nature 340,426-8 (1989)
485. A. Townsend, C Ohlen, I Bastin, H.-G. Ljunggren, L. Foster, and K. Karre. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 340,443-8 (1989)
486. E. J. Baas, H.-M. van Santen, M. 1 Kleijmeer, H. J. Geuze, P. J. Peters, and H. L. Ploegh. Peptide-induced stabilization and intracellular localization of empty HLA class I complexes. J. Exp. Med. 176,147-56 (1992)
487. T. A. Potter, R. A. Zeff, A. M. Schmitt Verhulst, and TV. Rajan. Molecular analysis of an EL4 cell line that expresses H-2Db but not H-2Kb or beta2-microglobulin. Proc. Natl. Acad. Sci. USA 82,2950-4 (1985)
488. H.Wang, G. G. Capps, R E Robinson, and M. C Zuniga. Ab initio association with beta 2-microglobulin during biosynthesis of the H-2Ld class I major histocompatibility complex heavy chain promotes proper disulfide bond formation and stable peptide binding. J. Biol. Chem. 269,22276-81 (1994)
489. V. Ustrell, G. Pratt, and M. Rechsteiner. Effects of interferon gamma and major histocompatibility complex-encoded subunits on peptidase activities of human multicatalytic proteases. Proc. Natl. Acad. Sci. USA 92,584-8 (1995)
490. M. Groll, L. Ditzel, J. Lowe, D. Stock, M. Bochtler, H. D. Bartunik, and R. Huber. Structure of 20S proteasome from yeast at 2.4 A resolution. Nature 386,463-531 (1997)
491. P. Parham. Flying the first class flag. Nature 357,1934 (1992)
492. 2-microglobulin complexes associate with TAP transporters before peptide binding. Nature 368,864-7 (1994)
493. A. Hill and H. Ploegh. Getting the inside out: The transporter associated with antigen processing (TAP) and the presentation of viral antigen. Proc. Natl Acad. Sci. USA 92,341-3 (1995)
494. T. N. Schumacher, D.V. Kantesaria, M.T. Heemels, P. G. Ashton Rickardt, J. C Shepherd, K. Fruh, Y.Yang, P. A. Peterson, S.Tonegawa, and H. L Ploegh. Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator. I Exp. Med. 179,533-40 (1994)
495. M.T. HeemeIs,T. N. Schumacher, K-Wonigeit, and H. L Ploegh. Peptide translocation by variants of the transporter associated with antigen processing. Science 262,2059-63(1993)
496. M. R. Jackson, M. F. Cohen-Doyle, P. A. Peterson, and D. B. Williams. Regulation of MHC class I transport by the molecular chaperone, calnexin (p88, IP90). Science 263,384-7 (1994)
497. E Degen and D R Williams. Participation of a novel 88-kD protein in the biogenesis of murine class I histocompatibility molecules. I Cell BioL 112,1099-115 (1991)
498. L. Margolese, G. L. Waneck, C K. Suzuki, E Degen, R. A. Flavell, and D. B. Williams. Identification of the region of the class I histocompatibility molecule that interacts with the molecular chaperone, p88 (calnexin, IP90). J. Biol. Chem. 268,17959-66 (1993)
499. E S. Song,Y Yang, M. R. Jackson, and P. A. Peterson. In vivo regulation of the assembly and intracellular transport of class I major histocompatibility complex molecules. J. Biol. Chem. 269,7024-9 (1994)
500. G G. Capps and M. C Zuniga. Class I histocompatibility molecule association with phosphorylated calnexin. J. Biol. Chem. 269,11634-9 (1994)
501. S. L. Schmid and M. R. Jackson. Making class II presentable. Nature 369,103-4 (1994)
502. A.TuIp, D.Verwoerd, B. Dobberstein, H. L. Ploegh, and I Pieters. Isolation and characterization of the intracellular MHC II compartment. Nature 369,120-6 (1994)
503. S. Amigorena, J. R. Drake, P.Webster, and I. MellmaaTransient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature 369,113-20 (1994)
504. M. A. West, J M. Lucocq, and C Watts. Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells. Nature 369,147-51 (1994)
505. P. A. Roche, C L. Teletski, E Stang, Q Bakke, and E O. Long. Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization. Proc. Natl. Acad. Sci. USA 90,8581-5 (1993)
506. A. Lanzavecchia, P. A. Reid, and CWatts. Irreversible association of peptides with class II MHC molecules in living cells. Nature 357,249-52 (1992)
507. V. Hsu, L. CYuan, J. G. Nuchtern, J. Lippincott-Schwartz, G. J. Hammerling, and R. Klausner. A recycling pathway between the endoplasmic reticulum and the Golgi apparatus for retention of unassembled MHC class I molecules. Nature 352,441-4 (1991)
508. S. E. Moore and R. G. Spiro. Inhibition of glucose trimming by castanospermine results in rapid degradation of unassembled major histocompatibility complex class I molecules. J. Biol. Chem. 268,3809-12 (1993)
509. T. S. Jardetzky.W S. Lane, R. A. Robinson, D. R. Madden, and D. CWiley. Identification of self peptides bound to purified HLA-B27. Nature. 353,326-9 (1991)
510. M. C. Zuniga, B. Malissen, M. McMillan, P. R. Brayton, S. S. Clarck, J. Forman, and L, Hood. Expression and function of tranplantation antigens with altered or deleted cytoplasmic domains. Cell 34,535-44 (1983)
511. M. C. Zuniga and L. Hood. Clonal variation in cell surface display of an H-2 protein lacking a cytoplasmic tail. J. Cell Biol. 102,1-10 (1986)
512. M. L. Fahnestock, J. M. Dadgari, M. McMillan, and P. 1 Bjorkman. Phosphatidyl inositol-linked forms of a murine class I MHC molecule expressed on Chinese hamster ovary cells retain peptide binding capability and alloreactivity. Int. Immunol. 6,307-14 (1994)
513. M. A.Vega and J. L. Strominger. Constitutive endocytosis of HLA class I antigens requires a specific portion of the intracytoplasmic tail that shares structural features with other endocytosed molecules. Proc. Natl. Acad. Sci. USA 86,2688-92(1989)
514. C. G. Capps, M. van Kampen, C. LAVard, and M. C. Zuniga. Endocytosis of the class I major histocompatibility antigen via a phorbol myristate acetate-indudble pathway is a cell-specific phenomenon and requires the cytoplasmic domain. J. Cell Biol. 108,1317-29(1989)
515. C. G. Capps and M. C. Zuniga. The cytoplasmic domain of the H-2Ld class I major histocompatibility complex molecule is differentially accessible to immunological and biochemical probes during transport to the cell surface. J. Biol. Chem. 268,21263-70 (1993)
516. J. H. Hochman, H. Jiang, L. Matyus, M. Edidin, and B. Pernis. Endocytosis and dissociation of class I MHC molecules labeled with fluorescent beta-2 microglobulin. J. Immunol. 146,1862-7 (1991)
517. U. M. A. Motal, X. Zhou, A. Joki, A. R. Siddiqi, B. R. Srinivasa, K. Stenvall, J. Dahmen, and M. Jondal. Major histocompatibility complex class I-binding peptides are recycled to the cell surface after intemalization. Eur. J. Immunol. 23,3224-9(1993)
518. J.-L, Cousin, M. Samson, P. F. Pilch, and M. Fehlman. Intemalization of insulin receptors and HLA antigens in human hepatoma cells. Biochem. J. 242,403-10(1987)
519. P. A. Reid and C. Watts. Cycling of cell-surface MHCglycoproteins through primaquine-sensitive intracellular compartments. Nature 346,655-7 (1990)
520. H. Allen, J. Fraser, D. Flyer, C. Calvin, and R. Flavell. b2-microglobulin is not required for cell surface expression of the murine class I histocompatibility antigen H-2Db or of a truncated H-2Db. Proc. Natl. Acad. Sci. USA 83,7447-51 (1986)
521. R. J. Rubocki, J. M. Connolly.T. H. Hansen, R. W. Melvold, R. S. Kim, W. H. Hildebrand, and 1 Martinko. Mutation at amino acid position 133 of H-2Dd prevents beta 2m association and immune recognition but not surface expression. J. Immunol. 146,2352-7 (1991)
522. K. L. Rock, U Rothstein, S. Gamble, and B. Benacerraf. Reassociation with b2-microglobulin is necessary for Kb class I major histocompatibility complex binding of exogenous peptides. Proc Natl. Acad Sci. USA 87,7517-21 (1990)
523. K. L. Rock, S. Gamble, L. Rothstein, and B. Benacerraf. Reassociation with b2-microglobulin is necessary for Db class I major histocompatibility complex binding of an exogenous influenza peptide. Proc. Natl. AcadL Sci. USA 88,301-4(1991)
524. 2-microglobulin dissociation rate is an accurate measure of the stability of MHC class I heterotrimers and depends on which peptide is bound. J. Immunol. 149,1896-904 (1992)
525. 2-microglobulin leads to the accumulation of a substantial pool of inactive class I MHC heavy chains on the cell surface. Cell 65,611-20 (1991)
526. S. Demaria, R. Schwab, S. R. Gottesman, and Y. Bushkin. Soluble beta 2-microglobulin-free class I heavy chains are released from the surface of activated and leukemia cells by a metalloprotease. J. Biol. Chem. 269,6689-94 (1994)
527. B. J. Webb, M. R. Bochan, A. Montel, L. M. Padilla, and Z Brahmi. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum. Cell Immunol. 159,246-61 (1994)
528. S. C. Spencer and IW Fahre. Water-soluble form of RT1.A class IMHC molecules in the kidney and liver of the rat. Immunogenetics 25,91-8 (1987)
529. 2-microglobulin. Proc. Natl. Acad. Sci. USA 89,7767-71(1992)
530. 2-microglobulin. J. Exp. Med. 171,1431-42(1990)
531. J. A. Madrigal, M. P. Belich, R. J. Benjamin, A.-M. Little,W. H. Hildebrand, D. L. Mann, and P. Parham. Molecular definition of a polymorphic antigen (LA45) of free HLA-A and -B heavy chains found on the surfaces of activated B and T cells. J. Exp. Med. 174,1085-95 (1991)
532. J. D. Smith,W.-R. Lie, J. Gorka, C. S. Kindle, N. B. Myers, and T. H. Hansen. Disparate interaction of peptide ligand with nascent versus mature class I major histocompatibility complex molecules: Comparisons of peptide binding to alternative forms of Ld in cell lysates and the cell surface. J. Exp. Med. 175,19120-2(1992)
533. G. G. Capps, B. E. Robinson, K. D. Lewis, and M. C. Zuniga. In vivo dimeric association of class I MHC heavy chains. J. Immunol. 151,159-69 (1993)
534. A. Chakrabarti, J. Matko, N. A. Rahman, B. G. Barisas, and M. Edidin. Self-association of class I major histocompatibility complex molecules in liposome and cell surface membranes. Biochemistry 31,7182-9 (1992)
535. J. Matko,Y Bushkin.T.Wei, and M. Edidin. Clustering of class I HLA molecules on the surfaces of activated and transformed human cells. J. Immunol. 152,3353-60(1994)
536. H. J. Ryser, E M. Levy, R. Mandel, and G. J. DiSciullo. Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction. Proc. Natl. Acad. Sei. USA 91,4559-63(1994)
537. F. R. Maxfield, J. Schlessinger.Y. Scheeler, I. Pastan, and M. C. Willingham. Collection of insulin, EGF and alpha(2)-macroglobulin in the same patches on the surface of cultured fibroblasts and common intemalization. Cell 14,805-10(1978)
538. F. Slang, J. Kartenbeck, and R. G. Parton. Major histocompatibility complex class I molecules mediate association of SV40 with caveolae. MoL Biol. Cell 8,47-57(1997)
539. M. J. Gething and I Sambrook. Protein folding in the cell Nature. 355,33-45 (1992)
540. F. U. Hartl. Molecular chaperones in cellular protein folding. Nature. 381,571-9 (1996)
541. S. M. Dintzis,V. EVelculescu, and S. R. Pfefler. Receptor extracellular domains may contain trafficking information. J. Biol. Chem. 269,12159-66 (1994)
542. I. Leconte, J. L. Carpentier, and E Clauser. The functions of the human insulin receptor are affected in different ways by mutation of each of the four N-glycosylation sites in the b subunit. J. Biol. Chem. 269,18062-71 (1994)
543. M. K. Uyenoyama. Coevolution of the Major Histocompatibility Complex and the t-Complex in the Mouse. I. Generation and Maintenance of High Complementarity. Genetics 121,139-51 (1989)
544. M. K. Uyenoyama. Coevolution of the Major Histocompatibility Complex and the t-Complex in the Mouse. II. Modification of Response to Sharing of Histocompatibility Antigens. Genetics 121,153-61 (1989)
545. M. B. Yaffe, G.W. Farr, D. Miklos, A. L. Horwich, M. L. Sternlicht, and H. Stemlicht.TCPl complex is a molecular chaperone in tubulin biogenesis. Nature 358,245-8 (1992)
546. V. A. Lewis, G. M. Hynes, D. Zheng, H. Saibil, and K.Willison.T-complex polypeptide-I is a subunit of a heteromeric particle in the eukaryotic cytosoL Nature 358,249-52(1992)
547. C. E. Creutz, A. Liou, S. L. Snyder, A. Brownawell, and K.Willison. Identification of the major chromaffin granule-binding protein, chromobindin A, as the cytosolic chaperonin CCT (chaperonin containing TCP-1). J. Biol. Chem. 269,32035-8(1994)
548. J. Schlessinger, I. Lax, and M. Lemmon. Regulation of growth factor activation by proteoglycans: What is the role of the low affinity receptors. Cell 83,357-60(1996)
549. S. M. Tompkins, J. C. Moore, and P. E. Jensen. An insulin peptide that binds an alternative site in class II major histocompatibility complex. J. Exp. Med. 183,857-66(1996)
550. E .Smeraldi and R. Scorza-Smeraldi. Interference between anti-HLA antibodies and chlor promazine. Nature 260,532-3 (1976)
551. F. H. Claas, J. M. van Ree,W M.Verhoeven, J. J. van der Poel,W.Verduyn, D. de Wed, and J. J. van Rood. The interaction between gamma-type endorphins and HLA class I antigens. Hum. Immunol. 15,347-56 (1986)
552. F. H. Claas and J. J. van Rood. The interaction of drugs and endogeneous substances with HLA class-I antigens. Prog. Allergy. 36,135-50 (1985)
553. M. S. Robinson, C. Watts, and M. Zerial. Membrane dynamics in endocytosis. Cell 84,13-21 (1996)